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Liver-specific β-catenin knockout (β-catenin-LKO) mice have revealed an essential role 
of β-catenin in metabolic zonation where it regulates pericentral gene expression and in initiating 
liver regeneration (LR) after partial hepatectomy (PH), by regulating expression of Cyclin-D1. 
However what regulates β-catenin activity in these events remains an enigma. Here, we 
investigate to what extent β-catenin activation is Wnt-signaling dependent and the potential cell 
source of Wnt ligands. We studied liver-specific Lrp5/6 KO (Lrp-LKO) mice where Wnt-
signaling was abolished in hepatocytes while the β-catenin gene remained intact. Intriguingly, 
like β-catenin-LKO mice, Lrp-LKO exhibited a defect in metabolic zonation observed as lack of 
glutamine synthetase (GS), Cyp1a2 and Cyp2e1. Lrp-LKO also displayed a significant delay in 
initiation of LR due to absence of β-catenin-TCF4 association and lack of Cyclin-D1. Given the 
important role of Wnt signaling, we further aimed to address the cellular source of Wnt ligands 
in liver. Q-PCR analysis showed distinct Wnt expression pattern in individual hepatic cell types 
before and after PH. To elucidate the role of different liver cell populations in Wnt secretion, we 
investigated conditional Wntless (Wls) KO mice, which lacked ability to secrete Wnts from 
hepatic cell populations, including liver epithelial cells (Wls-LKO), hepatic stellate cells (Wls-
SKO), macrophages including Kupffer cells (Wls-MKO), and endothelial cells (Wls-EKO). Wls-
LKO, Wls-SKO and Wls-MKO did not show any defect in hepatic zonation. Wls-EKO had 
decreased mRNA expression of zonal genes, which suggests that endothelial cells derived Wnts 
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may be important for maintaining zonation. After PH, Wls-LKO and Wls-SKO showed normal 
initiation of LR; however, Wls-MKO and Wls-EKO showed a significant deficit in LR. At later 
time points after PH, Wls-LKO had temporarily enhanced LR. Our experiments show that 
hepatocytes are capable of secreting Wnt5a during late stage of LR, which has an antagonistic 
role on Wnt/β-catenin pathway, while the hepatocytes from Wls-LKO cannot. Conclusion: Wnt-
signaling is the major upstream effector of β-catenin activity in pericentral hepatocytes and 
during LR. Hepatocytes, cholangiocytes, hepatic stellate cells or macrophages are not the source 
of Wnts in regulating hepatic zonation, while endothelial cells may be involved in this process. 
On the other hand, Kupffer cells and endothelial cells are major contributing sources of Wnt 
secretion necessary for β-catenin activation during LR. Hepatocytes might secrete inhibitory 
Wnts involved in the termination of LR. 
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1.0  INTRODUCTION 
β-catenin is a transcriptional co-activator that regulates genes critical for cell proliferation 
and differentiation. β-catenin signaling plays a critical role in liver development, liver metabolism 
& regeneration, and aberrant β-catenin signaling is also associated with liver cancer [1]. The major 
pathway that activates β-catenin is the canonical Wnt/β-catenin signaling pathway. Additional 
signaling pathways can also activate β-catenin in a Wnt-independent manner. Wnt ligands can also 
transduce signals through downstream effectors other than β-catenin. β-catenin has been 
demonstrated to be a crucial regulator for maintaining liver homeostasis and initiating liver 
regeneration after partial hepatectomy, while the upstream signals that activate β-catenin in these 
processes are not fully understood. 
1.1 THE WNT/BETA-CATENIN PATHWAY 
β-catenin is a transcriptional co-activator that regulates genes critical for cell proliferation 
and differentiation. Numerous pathways can activate β-catenin, the major one being the canonical 
Wnt/β-catenin signaling. Additional signaling, such as receptor tyrosine kinases (RTK) and protein 
kinase A (PKA), can also activate β-catenin. Other than β-catenin, Wnt ligands also activate other 
pathways (non-canonical Wnt signaling pathway). 
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1.1.1 The canonical Wnt/β-catenin signaling pathway 
 Wnt/β-catenin signaling is referred to as the “canonical pathway” which is characterized as 
the major pathway that activates β-catenin.  It is a highly regulated pathway controlled by multiple 
factors in this cascade (Figure 1). Wnts are secreted cysteine rich glycoproteins from epithelial, 
mesenchymal, and endothelial cells. Upon binding of Wnts to their receptor, the signaling cascade 
is activated, resulting in the activation of β-catenin.  
            In most normal adult cells, the Wnt/β-catenin pathway is turned off. This homeostasis is 
ensured by the absence of Wnts and the presence of the destruction complex that degrades β-
catenin. Extracellular Wnts can interact with antagonists like secreted frizzled-related protein 
(sFrp) and dickkopf (Dkk) family members, preventing the activation of the signaling cascade. 
Cytoplasmic β-catenin is bound in a degradation complex with Axin, adenomatous polyposis coli 
(APC), casein kinase 1 (CK1) and glycogen synthase kinase-3β (GSK-3β). β-Catenin is 
phosphorylated by CK1 and GSK-3β at specific serine/threonine residues  [2]. The phosphorylated 
β-catenin is targeted for ubiquitination.  
Binding of Wnts to the Frizzled receptor (Fz) induces association with low density 
lipoprotein receptor-related protein 5 and 6 (Lrp5/6). The Fz-Lrp5/6 co-receptor complex triggers 
activation of the canonical Wnt/β-catenin pathway. Dishevelled (Dsh) is recruited to Fz, and the 
Fz/Dsh complex further recruits Axin to Lrp5/6 [3]. GSK-3β and CK1 then phosphorylates Lrp5/6 
instead of β-catenin, which results in the inactivation of GSK-3β [4-6]. The dephosphorylated β-
catenin is released from the degradation complex and accumulates in the cytoplasm, further β-
catenin translocates into the nucleus where it binds to T-cell factor/lymphoid enhancing factor-4 
(TCF/LEF4), and triggers the transcription of target genes [7]. Numerous factors playing crucial 
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roles in cell proliferation and survival have been shown to be the downstream targets of β-catenin, 
such as cyclin-D1, c-Myc and so on. 
 
Figure 1. The canonical Wnt/β-catenin signaling pathway 
(A) In homeostasis, the pathway is turned off. (B) Active signaling.  APC, adenomatous polyposis coli; β-cat, β-
catenin; CK, casein kinase; DKK, dickkopf; DSH, dishevelled; GBP, GSK3-binding protein; GSK, glycogen synthase 
kinase; LRP, LDL receptor-related protein; P, phosphorylation; sFRP, secreted Frizzled-related protein; TCF, T-cell 
factor.  
 
1.1.2 Wnt-independent pathways that activate β-catenin 
β-catenin can also interact with several receptor tyrosine kinases (RTKs) (Figure 2). 
Hepatocyte growth factor (HGF), a known mitogen for the liver [8], can activate β-catenin. This 
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effect is mediated through its receptor, MET, a RTK expressed in hepatocytes. Binding of HGF to 
its receptor activates the kinase activity of MET. Phosphorylated Met further phosphorylates β-
catenin at tyrosine residues 654 and 670, which stabilizes β-catenin and results in its translocation 
to the nucleus and up-regulation of target genes [9, 10]. β-catenin also appears to interact with the 
epidermal growth factor receptor (EGFR), which is also a RTK. The ligand for EGFR, epidermal 
growth factor (EGF), is another known hepatocyte mitogen. Like MET, EGFR phosphorylates β-
catenin at tyrosine residue 654 and stabilizes it [11]. Constitutive tyrosine phosphorylation of β-
catenin by EGFR has been implicated in the metastasis of cancers [12, 13].  
 Cyclic AMP (cAMP)-dependent protein kinase (protein kinase A [PKA]) can also activate 
β-catenin by stabilizing it (Figure 2). Activation of PKA increased the cytoplasmic and nuclear β-
catenin level, leading to TCF dependent transcription through β-catenin. Phosphorylation of β-
catenin at Serine 675 and 552 by PKA inhibits ubiquitination of β-catenin, causing β-catenin to 
accumulate and target gene expression to be turned on [14, 15]. Mutation of Serine 675 of β-
catenin attenuates the inhibition of ubiquitination of β-catenin by PKA, confirming that PKA 
stabilizes β-catenin by phosphorylating it [14, 15]. 
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Figure 2. Wnt-independent pathways that activate -catenin 
Upon binding of growth factors (GFs) to receptor tyrosine kinase (RTK), RTK phosphorylates β-catenin at Tyrosine 
654 and 670. Protein kinase A (PKA) can also phosphorylate β-catenin at Serine 552 and 675. The phosphorylation 
makes β-catenin stable and leads to its translocation into the nucleus. 
 
1.1.3 The non-canonical Wnt pathway 
Wnts can transduce signals through both canonical and non-canonical signaling pathways. 
The non-canonical Wnt signaling pathway includes those pathways that use downstream effectors 
other than β-catenin–TCF/LEF, often referred to as the β-catenin-independent pathway [16]. These 
non-canonical Wnt pathways play important roles in development, but their relationship to the 
canonical Wnt/β-catenin signaling remains elusive [17]. These pathways can be divided into two 
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distinct branches, the planar cell polarity pathway (PCP pathway) and the Wnt/Ca
2+
 pathway 
(Figure 3). 
1.1.3.1 The PCP and Wnt/Ca2+ pathway 
The best-characterized β-catenin independent pathway is the planar cell polarity (PCP) 
pathway. In PCP signaling, Wnt-frizzled complex activates small GTPases RAC1 and Ras 
homolog gene family, member A (RHOA), and c-Jun N-terminal kinase (JNK) is the downstream 
effector in this signaling cascade (Figure 3A). This pathway regulates cell polarity in 
morphogenetic processes in vertebrates, such as gastrulation and neural tube closure [18-20].  
Another non-canonical Wnt pathway is the Wnt/Ca
2+
 pathway (Figure 3B). Upon binding 
of Wnts to frizzled receptor, heterotrimeric G protein is activated, which in turn activates 
phospholipase C (PLC).  PLC further triggers Ca
2+
 release from intracellular store, which further 
activates cell division control protein 42 homolog (CDC42) and calcineurin [17, 21]. CDC42 
mediates tissue separation and cell movements during gastrulation. Calcineurin activates 
transcription factor NF-AT to regulate ventral cell fate by suppressing canonical Wnt/β-catenin 
during axis formation [22]. 
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Figure 3. Non-canonical Wnt signaling 
(A) Planar cell polarity (PCP) pathway, (B) Wnt-Ca
2+ 
pathway.  
CDC, cell division cycle related; JNK, c-Jun N-terminal kinase; JUN, jun proto-oncogene; NFAT, nuclear factor of 
activated T cells; PLC, phospholipase C; RAC, Ras related GTPase; RHOA, Ras homolog gene family, member A. 
 
1.1.3.2 Wnt5a: a non-canonical Wnt ligand 
Wnt5a is classified as a non-canonical Wnt family member [21, 23]. Wnt5a can activate the 
Wnt/Ca
2+
 pathway in the presence of Frizzled receptors [24-26]. It has been shown that Wnt5a 
stimulates the frequency of calcium fluxes in zebrafish embryos. The Wnt5a mutant exhibited 
reduced Ca
2+
 release, increased β-catenin accumulation and activation of downstream targets, 
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therefore suggesting the antagonistic role of Wnt/Ca
2+
 pathway against canonical Wnt/β-catenin 
activity [27]. Meanwhile, Wnt5a can activate the canonical Wnt/β-catenin pathway leading to the 
expression of downstream genes in the presence of Frizzled 4 receptor [28]. Other than these two 
signaling pathways, Wnt5a also transduces signals through receptor Ror2. Ror2 is a member of the 
Ror-family of receptor-tyrosine kinases. Ror2 mediates Wnt5a signaling by inhibiting the 
canonical Wnt/β-catenin pathway and activating Wnt/c-Jun N-terminal kinase (JNK) pathways 
[29]. This pathway is involved in the regulation of various cellular functions [30-32]; however, it 
remains elusive how this pathway regulates expression of the downstream targets. 
The effect of Wnt5a signaling on canonical Wnt/β-catenin signaling is still controversial; 
however various studies have demonstrated an antagonistic role of Wnt5a on the β-catenin 
pathway. Wnt5a inhibits the activities of Wnt1 in Xenopus development [33]. Wnt5a knockout 
mice exhibit an enhanced β-catenin pathway [34, 35].  It has also been shown that Wnt5a acts as a 
tumor suppressor by inhibiting the Wnt/β-catenin signaling pathway. In thyroid cancer, Wnt5a 
suppresses tumors by inhibiting c-myc, a well-known oncogene and downstream target of the 
Wnt/β-catenin pathway [36]. In colon cancer, Wnt5a can inhibit constitutively active β-catenin in 
APC-mutated cells in an autocrine manner [37]. However, the function of Wnt5a in liver 
homeostasis and regeneration has not been addressed. 
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1.2 THE ROLE OF BETA-CATENIN IN LIVER HOMEOSTASIS 
1.2.1 Hepatic zonation 
The smallest functional unit in the liver is the hepatic lobule. The hepatic lobule appears to 
be histologically homogeneous; in fact, hepatocytes exhibit a striking functional heterogeneity. 
Metabolic processes are arranged in a gradient based on the functional heterogeneity of 
hepatocytes, which is known as hepatic zonation [38-40]. Blood enters the hepatic lobule through 
the hepatic artery and portal vein at the portal trial, and travel towards the central vein in the 
middle. Based on the location within the hepatic lobule, periportal, midzonal and pericentral 
hepatocytes are defined (Figure 4). Intriguingly, hepatocytes in different zones are functionally 
different due to differences in gene expression levels.  
A hepatic lobule is divided into three zones: pericentral zone, which surrounds the central 
vein, periportal zone, which surrounds the portal triad (contains hepatic artery, portal vein and bile 
duct), and midzonal hepatocytes in between (Figure 4).  Periportal and pericentral hepatocytes can 
be distinguished according to differences in their function. It is known that genes that encode for 
enzymes critical for ammonia and xenobiotic metabolism are predominantly expressed in 
pericentral hepatocytes. On the contrary, periportal hepatocytes express genes important for urea 
synthesis [41-44]. Consequently, the major metabolic functions of the liver exhibit differences in 
activity within the pericentral and periportal zones. It is generally accepted that the homeostatic 
function of the liver depends on the functional compensation of the two zones. 
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Figure 4. Schematic diagram of the hepatic lobule 
The structure of hepatic lobule resembles a roughly hexagonal shape. Hepatocytes radiate out from the central vein. 
According to the location of hepatocytes within the lobule, pericentral, midzonal and periportal hepatocytes are 
defined. CV: Central vein, HA: hepatic artery, PV: portal vein, BD: bile duct. 
 
 
1.2.2 The role of β-catenin in regulating hepatic zonation 
Observations in liver tumors first indicated a role for β-catenin in regulating hepatic 
zonation. It has been found that liver tumors in mice harboring activating β-catenin mutations 
exhibit altered hepatic zonation, which is characterized by glutamine synthetase (GS) expression 
throughout the lesion [45]. Such findings in liver tumors suggest that β-catenin may be required for 
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mediating the expression of zone-specific genes.  
Follow-up studies have unequivocally established the critical role of β-catenin signaling in 
hepatic zonation. It is believed that the differential zonal expression and activation of β-catenin and 
APC determines the pericentral versus periportal phenotype. In liver homeostasis, the activation of 
β-catenin signaling is confined to the pericentral zone. Pericentral hepatocytes express cytoplasmic 
and nuclear β-catenin in addition to membranous localization. It is known that genes that encode 
for enzymes critical in ammonia and xenobiotic metabolism are predominantly expressed in 
pericentral hepatocytes. These genes include GS, cytochrome P450 family members such as 
Cyp2e1 and Cyp1a2, which are downstream targets of β-catenin. On the contrary, periportal 
hepatocytes show higher expression of APC that can sequester β-catenin and as a consequence 
lower unbound, dephosphorylated β-catenin [46, 47]. These hepatocytes express genes encoding 
for urea synthesis such as arginase 1 and carbamoylphosphate synthase (CPS).  
The key role of β-catenin signaling in dictating hepatic zonation was confirmed by a 
hepatocyte specific, β-catenin knockout mice model. Liver specific loss of β-catenin resulted in 
loss of GS, Cyp1a2 and Cyp2e1 expression from pericentral hepatocytes [48, 49]. Blocking β-
catenin signaling repressed the pericentral genetic program, with the periportal genetic program 
expressed throughout the lobule [46, 48, 50]. On the other hand, using mice with liver-targeted 
inactivation of APC, it has been shown that the activation of β-catenin signaling induced the 
expression of a pericentral genetic program throughout the entire lobule, together with repression 
of the periportal genetic program [46] (Figure 5).  
Although the interaction of β-catenin and APC is of essence in dictating hepatic zonation, it 
may not fully explain the striking demarcation between different zones. Immunohistochemistry 
showed a striking demarcation between the GS (a pericentral gene) and CPS (a periportal gene) 
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expressing zones [46, 49]. However, if a gradient of β-catenin/APC truly exists, a more gradual 
change in the expression pattern of zonation markers would be predicted. Therefore, additional 
signaling pathways or other components of the Wnt/β-catenin pathway may also be involved in the 
regulation of hepatic zonation. 
 
Figure 5. Opposing effects of the activation and inactivation of β-catenin signaling in mouse liver 
(A) Wild-type liver, β-catenin signaling is active in pericentral hepatocytes. (B) β-catenin KO and APC-KO livers. β-
catenin KO liver is periportal like, with periportal genetic program expressed throughout the lobule; APC-KO liver is 
pericentral like, with pericentral genetic program expressed throughout the lobule. 
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1.3 THE ROLE OF BETA-CATENIN IN LIVER REGENERATION 
1.3.1 Introduction of liver regeneration 
Liver is an intriguing organ with unique capacity to regenerate in response to the loss of liver 
mass or injuries. As a biochemical defense against toxic chemicals and re-processor of absorbed 
substrates, liver may be periodically exposed to harmful insults. The capability to regenerate has 
evolved to safeguard the wide range of functions performed by liver and serves as a mean to 
restore and repair liver function after injuries. 
         Liver regeneration (LR) is not dependent on a small group of progenitor cells, but instead 
carried out by proliferation of all the existing mature cell populations composing the entire organ, 
including hepatocytes, cholangiocytes, sinusoidal endothelial cells, Kupffer cells and stellate cells 
[51]. During liver regeneration, genes involved in protein synthesis, posttranslational processing 
and cytoskeletal assembly are upregulated early, followed by genes associated with metabolism 
[52, 53]. 
 
1.3.2 Clinical implication of studying liver regeneration 
            The only cure for end-stage liver disease is liver transplantation, which is a great 
technological achievement. However, donor organ availability cannot meet demand and many 
patients die on the waiting list. For patients who have no access to liver transplantation, successful 
regeneration leads to the restoration of liver function and survival, whereas insufficient 
regeneration results in liver failure and death. For this reason, it is necessary to understand the 
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mechanisms controlling LR, to identify factors and signaling pathways that could be 
therapeutically targeted and to develop methodologies to stimulate LR. 
Enhancing LR pharmacologically by targeting some critical factors or signaling pathways 
would have far reaching implications and benefit a considerable amount of patients. Studies on the 
molecular basis of LR have revealed a series of transcription factors and signaling pathways 
associated with the initiation of LR. Pharmacologically inducing such pro-regenerative factors or 
activating pro-regenerative pathways could potentially enhance LR. Therefore, it is one of crucial 
aspects how understanding of the molecular mechanism controlling LR might be beneficial for 
clinical scenarios. 
 
1.3.3 Liver regeneration induced by partial hepatectomy 
            LR is regulated by an intricate signaling network involving the interplay between various 
liver cell populations. In vitro models could be helpful for the study of isolated signal pathway, 
however, they always need to be validated using in vivo studies so as to simulate the interactions 
between the various cell populations in the liver. Currently, there is a broad range of experimental 
animals of different species and strategies for inducing LR. Since cell proliferation in the healthy 
liver is a rare event, the first step to initiate the regeneration response is to induce a liver injury in 
these animal models. Surgical resection has been widely used to experimentally induce LR. 
1.3.3.1 Two thirds partial hepatectomy 
Surgical resection is one of the most frequently and widely used techniques to initiate LR. 
The induction of LR by partial hepatectomy (PH) depends on the removal of functional liver mass. 
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The model of 2/3 PH in rodents was introduced by Higgins and Anderson [54]. The rodent liver 
has multiple lobes, and removing two thirds of the total liver mass can be easily accomplished by a 
surgical procedure, without damaging the remaining lobes. The residual lobes undergo 
proliferation and regain the original liver mass. This process is finished within one week in rats, 
about two weeks in mice [55]. 
PH in rodents involves ligation and resection of 2 from 4 lobes [56]. PH is well tolerated by 
rodents when appropriately performed. Induction of LR by PH bears some unique advantages. 
Since the rodents have uniform and consistent anatomy, the procedure has high accuracy and 
reproducibility. In addition, surgical resection can be performed in minutes, the induction of 
regeneration begins at one point in time, and therefore, the regenerative process can be precisely 
timed. The reproducibility and standardization of PH makes this model highly popular and 
intensively studied. Furthermore, the residual liver is not directly manipulated at the time of the 
surgery, so regeneration occurs without being exposed to the influence of necrosis or 
inflammation. However, along with the advantages, there are some limitations innate to this model. 
PH model may simplify the regeneration process too much to make an adequate accounting of the 
human disease condition. In human patients, LR is usually associated with inflammation, innate 
immunity, tissue healing through removal of necrotic tissue and so on [56, 57]. The PH model 
allows distinct understanding of the regenerative process purely as a response to the loss of liver 
mass, but for a better understanding of the regenerative process in the context of human liver 
diseases, some of the pathological factors that could have influences on the regeneration process 
need to be eventually integrated with the PH model. 
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1.3.3.2 Cellular basis of liver regeneration after partial hepatectomy 
LR after PH features the proliferation of adult hepatic cell types. Hepatocytes are the first 
to proliferate. The kinetics of hepatocyte proliferation varies slightly in different species. The first 
peak of DNA synthesis in hepatocytes occurs around 24 hours after PH in rats and approximately 
36 hours in mice [55]. Hepatocytes can secrete growth stimuli and induce proliferation of the other 
cell types in liver. Cholangiocytes and stellate cells begin to synthesize DNA about 12 hours after 
the hepatocytes, reaching a peak at about 48 hours in rat [58]. Three days after PH, as a 
consequence of cell proliferation, liver is characterized by cell clusters containing 10-14 
hepatocytes. By day 4, stellate cells send processes between hepatocytes in the clusters and start 
producing several types of laminin. Following the penetration of stellate cells, sinusoidal 
endothelial cells also invade into the clusters, and in this manner the normal liver vasculature is 
restored [59].  
1.3.3.3 Molecular basis of liver regeneration after partial hepatectomy 
PH triggers a wide variety of gene expression and a series of cell signaling pathways that 
are under tight control. The expression of some early genes is induced during the first few hours 
after PH, which is termed the “priming phase”.  Many of the genes are involved in cytokine 
networks, such as TNF-α and IL-6. These cytokines can induce some critical transcription factors 
in the liver, including Stat3 and NF-κB, which in turn activate the genes that are responsible for 
promoting the quiescent hepatocytes to enter into the cell cycle [60, 61]. Cell cycle progression is 
then driven by growth factors, such as HGF and EGF [53, 62]. Some signaling pathways also 
become activated and play important roles in driving LR. Wnt/β-catenin signaling is one of the 
critical players activated following PH. 
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1.3.3.4  The role of Wnt/β-catenin signaling in triggering liver regeneration after partial 
hepatectomy 
           β-catenin signaling is a pro-proliferative and pro-survival signal that plays a vital role 
during LR after PH. β-catenin has been known to have a positive role in liver growth. Mice 
overexpressing β-catenin in the liver have increased hepatocyte proliferation and a 15% increase in 
liver size [63]. Transgenic mice expressing an oncogenic form of β-catenin developed 
hepatomegaly with increased hepatocyte proliferation without any compensatory apoptosis [64]. 
Given the growth advantage of β-catenin overexpressing liver, the question of whether β-catenin 
signaling also positively regulates LR after PH has been raised. Studies show that β-catenin 
signaling is rapidly activated following PH. In a rat model, there was a 2.5-fold increase in β-
catenin protein a few minutes after PH [65]. The increase in β-catenin during early stages of LR 
contributes to the increased expression of cyclinD1 and c-myc, which are both downstream targets 
of β-catenin and play an important role in driving cell cycle progression and cell proliferation [66, 
67] (Figure 6). 
 18 
 
Figure 6. The role of β-catenin in liver regeneration after PH 
Following PH, β-catenin signaling pathway becomes active. β-catenin translocates into the nucleus where it binds to 
TCF and turns on the expression of Cyclin-D1 and c-Myc, which is critical for the hepatocytes to enter into the cell 
cycle. Wnt ligands secreted from various nonparenchymal cell populations within the liver are important mitogenic 
signals that activate β-catenin. LSEC, liver sinusoidal endothelial cell. 
 
 
The importance of β-catenin signaling in LR is further validated in knockdown studies. 
Ablation of β-catenin by antisense oligonucleotides compromised LR after PH [68]. Hepatocyte-
specific disruption of β-catenin led to suboptimal liver regeneration after PH, with deficient 
expression of Cyclins-A, D, and E [49]. Hepatic DNA synthesis was also delayed in β-catenin 
knockout mice after PH [69]. While deletion of β-catenin reveals defects in LR, activation of this 
pathway has demonstrated the positive role of β-catenin signaling in LR. Zebrafish harboring 
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defects with APC, a negative regulator of β-catenin, display enhanced LR after PH, similar to mice 
with APC mutation [70]. Transgenic mice expressing constantly active forms of β-catenin also 
show a growth advantage during LR after PH [71].  
LR after PH is an intricate process that is tightly regulated by a complex signaling network. 
Delays in LR can always be observed by blocking some pro-proliferative signals or pathways, such 
as β-catenin, HGF, EGF and so on; however, not a single kind of signaling alone can drive the 
regeneration process. There is enormous redundancy and overlap in the function of those 
proliferative signals, so that regeneration can still complete itself in case that some pathways are 
missing or blocked. Understanding individual signaling contributors during LR process is of 
essential importance, which could help optimize this process and ensure the maximal efficiency of 
LR after PH. 
1.3.3.5 Termination of liver regeneration after partial hepatectomy 
After PH, the LR process terminates when the normal liver weight to body weight ratio has 
been re-established. Since hepatocytes have seemingly unlimited proliferative capacity [72, 73], 
there must exist some regulatory mechanisms to stop the LR process. How does the liver sense that 
the hepatic mass has been restored, and what are the signals that terminate LR after PH? Unlike the 
initiation of LR which has been extensively studied, the mechanisms leading to proper termination 
of LR are not well understood. Some of the factors and signaling pathways have been shown to 
play a role in the termination of LR.  
Transforming growth factor beta (TGFβ) has anti-proliferative effects and contributes to 
the termination of LR after PH. TGFβ can suppress hepatocyte proliferation in vitro [74]. 
Administration of TGF-β in hepatectomized rats inhibits the early proliferative response and leads 
to delay in hepatocyte DNA synthesis [75]. Disruption of TGF-β signaling combined inhibition of 
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activin A (a member of TGFβ family) in the liver enhances proliferation and leads to prolonged 
LR [76]. 
Extracellular matrix (ECM) signaling via integrins has an important role in proper 
termination of liver regeneration. ECM is a rich source of signaling to surrounding cells and such 
signaling is mediated through integrins [77]. Integrin-linked kinase (ILK) can interact with the 
cytoplasmic domains of β integrins and participates in the signaling transduction between ECM 
and cells [78]. Recent studies have revealed the role of ILK in regulating LR after PH. ILK 
deficient mice fail to terminate LR properly after PH, which renders larger livers reaching a size 
59% greater than the original liver [79].  
The ECM is a complex mixture of proteins and glycosaminoglycans. Glypican-3 (GPC3) is 
one of the components. GPC3 functions as a growth suppressor, and is involved in the termination 
of LR. Studies show that GPC3 level begins to increase 2 days after PH and peaks by day 5 [80].  
Blocking GPC3 expression promotes hepatocyte growth in culture [80], on the contrary, 
overexpression of GPC3 in mice suppresses hepatocyte proliferation and LR after PH [81].  
A series of pro-proliferative signaling turns on to initiate liver regeneration soon after PH, 
while turns off at later stages to prevent liver overgrowth and to terminate liver regeneration. 
Identifying the termination mechanisms of pro-proliferative signaling could be helpful to 
understand how LR stops. β-catenin is an essential pro-proliferative signaling that triggers LR after 
PH. In a rat model, β-catenin protein levels increase within several minutes after PH, concomitant 
with its translocation to the nucleus. However, β-catenin activation after PH was transient; as 
regeneration proceeds, this pathway is downregulated by activation of the destruction complex for 
β-catenin, so the protein level of β-catenin returns to normal by 48h, which is after the wave of 
hepatocyte proliferation [65]. This timely regulation allows β-catenin signaling to be activated to 
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trigger LR in early stages while limiting its sustained activation at later stages, thereby ensuring 
proper termination of LR processes. Thus, identification of the negative regulators of β-catenin 
signaling during late stages of LR may also be a component of the hepatostat. β-catenin is just one 
example among the numerous pro-proliferative signals whose activation and termination is under 
spatiotemporal constrains, and thus, exploring the termination mechanisms of these signaling 
pathways might provide useful insights into the understanding of eventual termination of LR. 
 
 
1.4 WNT SECRETION IN LIVER 
Wnt proteins are highly conserved palmitoylated glycoproteins secreted by epithelial, 
mural, or endothelial cells. The adult liver expresses numerous Wnts. All major cell types in the 
liver, hepatocytes, hepatic stellate cells (HSC), biliary epithelial cells (BECs), liver sinusoidal 
endothelial cells (LSECs) and Kupffer cells, express various kinds of Wnts [82]. However, the 
Wnt/β-catenin pathway is normally turned “off” in adult liver, thus this wide expression of Wnts 
might be in fact a balance between the “stimulatory” and “inhibitory” Wnts [83]. In homeostasis, 
only the β-catenin in the pericentral zone is active, but under stressed circumstances, such as PH, 
the Wnt/β-catenin pathway is rapidly activated to trigger liver regeneration (LR). Therefore, Wnt 
secretion must be tightly regulated to ensure the function of β-catenin in both liver homeostasis 
and during liver LR.  
 
 22 
1.4.1 Wntless: a critical regulator of Wnt secretion 
            There are proteins involved in Wnt protein processing and secretion from producing cells. 
Wntless (Wls) is a multipass transmembrane protein required in the secretory pathway to promote 
the release of Wnts from producing cells [84] (Figure 7).  
Wls localizes to the components of the secretory pathway, especially the Golgi [85-87] and 
the plasma membrane [88]. An interaction between Wls and Wnts has been predicted on the basis 
of colocalization and co-immunoprecipitation experiments [85]. The interaction between Wls and 
Wnts, and their localization to both the Golgi and the plasma membrane, suggest that they 
associate in the Golgi where they are incorporated into vesicles and transported to the plasma 
membrane. The current theory is that Wnts are palmitated by a membrane-bound acyltransferase, 
Porcupine, in the ER [89, 90]. Wls binds to the palmitate group of Wnts in the Golgi, and further 
associates with Wnts in the secretion vesicle. Wls acts as a cargo receptor, assisting Wnts to reach 
the plasma membrane, so that Wnts can be secreted to the extracellular matrix (Figure 7). The 
importance of Wls in Wnt secretion has been confirmed by depletion studies. Defect of Wls results 
in Wnt loss-of-function phenotypes [86, 87, 91, 92], suggesting that Wls is indispensable in Wnt 
secretion. 
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Figure 7. The role of Wls in Wnt signal secretion 
Wnt is palmitoylated by Porcupine in the lumen of the endoplasmic reticulum (ER). Upon reaching the Golgi, Wntless 
(Wls) associates with Wnt in vesicles bound for secretion, leading to secretion of Wnt into the extracellular matrix 
(ECM). 
 
 
The Wnt family consists of 19 secreted, cysteine-rich glycoproteins essential for 
embryogenesis and homeostasis. Wls appears to control the release of all Wnts, deletion of Wls 
leads to embryonic lethality in mice due to impairment of the developing body axis [93], therefore 
mice with a conditional null allele for Wls were generated. The utilization of Wls conditional 
mutants could be a powerful tool to study Wnt secretion under spatial and temporal control [94]. 
Cell-specific Wls deletion has divulged important roles of Wnt ligands in multiple organs [95-98]. 
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The crucial role of Wnt ligands in bone development and homeostasis has been revealed by 
generating osteoblast-specific Wls-deficient mice. Bone-mass accrual was significantly inhibited in 
knockout mice, with a dramatic reduction of both trabecular and cortical bone mass. The knockout 
animals had spontaneous fractures and a high frequency of premature lethality [96]. Wnts also 
regulates retina angiogenesis. Deletion of the Wls in retinal myeloid cells results in increased 
angiogenesis in the deeper layers and defective remodeling [95]. A mouse model with a defect of 
Wls in epidermis revealed functional roles of Wnt ligands in fibroblast proliferation and in the 
epidermal hair follicle initiation program [97]. Wnt ligands are also required for maintaining stem 
cell activity, while deletion of Wls in nail stem cells results in failure to regenerate the nail or digit 
[98].  
Taken together, the tissue specific genetic manipulation of Wls has been widely utilized to 
address the role of Wnt ligands in various organ systems under both physiological and pathological 
condition. However, the role of Wnt ligands secreted by different hepatic cell populations in liver 
homeostasis and regeneration remained unexplored; therefore, deletion of Wls in individual hepatic 
cell types might be of essence to elucidate this fundamental question. 
 
1.4.2 The role of different hepatic cell populations in Wnt secretion 
The liver sinusoid is the most basic functional unit of the liver (Figure 8). The liver 
sinusoid is a capillary lined by liver sinusoidal endothelial cells (LSECs). Hepatocytes, the 
parenchymal cells in the liver, are separated from the sinusoids by a small space called the space of 
Disse. Non-parenchymal cells are also located inside the sinusoids. Hepatic stellate cells (HSCs) 
can help to maintain the extracellular matrix, and Kupffer cells can take up and destroy foreign 
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materials. Bile canaliculi are small channels formed between adjacent hepatocytes to collect bile 
secreted by hepatocytes [99].  
 
Figure 8. The liver sinusoid functional unit 
 
 
All major cell types in the liver, including hepatocytes, HSCs, cholangiocytes, LSECs and 
Kupffer cells, express various kinds of Wnts [82]. It has been widely accepted that non-
parenchymal cells (NPCs) in the liver play important roles in maintaining liver homeostasis and 
regulating liver growth [100, 101]. Recent studies further show that NPCs are a source of 
proliferative signals during LR, secreting various factors including Wnt ligands. It has been 
reported that LSECs secrete Wnt2 and HGF to stimulate LR. Diminished expression of LSEC 
derived Wnt2 and HGF leads to defect of LR, while restoring their expression rescues the 
phenotype [102]. Macrophages are also a source of Wnt proteins in regenerating adult liver. 
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Macrophages induce Wnt3a expression and β-catenin activation to promote LR during chronic 
liver injury [103]. HSCs also seem to play an important role in LR by producing HGF to trigger 
cell proliferation [104].  
Although the role of β-catenin in liver homeostasis and LR has been intensively studied, 
the upstream signals that regulate β-catenin activity in these processes remains elusive. Wnt 
ligands are the most important upstream signals that activate β-catenin; however, the regulation of 
Wnt secretion and the cellular source of Wnt ligands that modulate β-catenin activity are not fully 
understood. Recent studies suggest that NPCs might be a critical source of several Wnt ligands 
during LR. However, there are still gaps in our knowledge that need to be filled in to fully 
understand the cellular source of Wnt proteins and their functions in the liver.  
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2.0  CENTRAL HYPOTHESIS AND RATIONALE 
There is accumulating evidence showing that β-catenin plays a critical role in maintaining 
normal liver function and in the process of liver regeneration (LR). Canonical Wnt-signaling is the 
major pathway that induces β-catenin activation [3]. Binding of Wnt to its cell surface receptor 
Frizzled and co-receptor Lrp5/6 stabilizes β-catenin protein that in turn translocates to the nucleus 
to bind to the T-cell factor (TCF) family of transcription factors in order to activate gene 
expression of tissue- and context-specific targets. Other than Wnt-signaling, β-catenin can also be 
activated in a Wnt-independent manner. Some examples include β-catenin activation by 
hepatocyte growth factor (HGF) by phosphorylation at tyrosine-654 (Y654) [9, 10], epidermal 
growth factor (EGF) by phosphorylation at Y654 [11], Flt3 also by phosphorylation at Y654 [105], 
and protein kinase A (PKA) by phosphorylation at serine-552 (S552) and -675 (S675) [14].   
The relative contribution of Wnt-dependent and Wnt-independent pathways to β-catenin 
activation in physiological context has not been addressed. Therefore, we aim to investigate to 
what extent β-catenin signaling in liver is Wnt dependent in both normal liver homeostasis 
and during LR, and identify the source of Wnts that modulate β-catenin activation in these 
processes.  
Aim 1: To investigate whether the function of β-catenin in maintaining liver 
homeostasis and triggering LR is Wnt-signaling dependent or not.  
β-Catenin is a transcriptional co-activator that plays a critical role in liver biology. In liver 
 28 
homeostasis, hepatocytes exhibit molecular heterogeneity based on their location within the 
hepatic lobule, which is known as hepatic zonation. β-catenin is one of the key molecules 
regulating the zonation pattern. Pericentral hepatocytes express cytoplasmic and nuclear β-catenin 
in addition to membranous localization, and regulate the expression of genes such as GS, and 
certain cytochrome P450 enzymes, such as Cyp1a2 and Cyp2e1 [106]. In addition, β-catenin 
signaling is also essential for the initiation of LR. Liver has the unique capacity to regenerate 
following partial hepatectomy (PH). During LR, a series of cell signaling pathways and cascades 
are triggered that are tightly regulated. β-Catenin signaling is one such pathway that is activated 
very early after PH [65].   
Indeed, we and others have previously shown that a liver-specific -catenin knockout (-
catenin-LKO) lacking this protein in both hepatocytes and cholangiocytes, shows defective 
pericentral gene expression and a 24 hour delay in the entry of hepatocytes to S-phase after PH 
with a peak at 72 hours and not 40 hours [48, 49]. However what the upstream regulator of -
catenin is in these events remains unknown. 
We have now generated liver-specific Lrp5/6 double knockout mice (Lrp-LKO) where 
upstream Wnt-signaling is abolished while β-catenin expression and downstream signaling is 
intact. Thus β-catenin in Lrp-LKOs can still be activated by signaling pathways other than Wnts 
(Figure 9). With this model, we can distinguish between Wnt-dependent and -independent β-
catenin signaling. In this aim, we test whether Lrp-LKOs phenocopy -catenin-LKOs in terms of 
defective hepatic zonation and delay in LR, and address to what extent -catenin activation is Wnt 
signaling dependent in these processes. 
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Figure 9. Comparison of liver specific β-catenin knockout and liver specific Lrp5/6 knockout mice 
In liver specific β-catenin knockout (β-catenin-LKO), both Wnt-dependent and Wnt-independent β-catenin signaling 
are abolished, and it results in defect of hepatic zonation and delay in liver regeneration. In liver specific Lrp5/6 
knockout (LRP-LKO), only Wnt-dependent signaling is abolish, while the Wnt-independent pathways remain intact 
and can activate β-catenin. 
 
 
Aim 2: To identify the cellular source of Wnt ligands that modulate the activation of 
β-catenin in dictating hepatic zonation and triggering LR.  
Various cell types in the liver express Wnts, including hepatocytes, hepatic stellate cells 
(HSCs), cholangiocytes, liver sinusoidal endothelial cells (LSECs) and Kupffer cells [107]. Studies 
have shown that non-parenchymal cells, such as HSC, LSEC and macrophages, secrete factors to 
stimulate LR [102-104]. However, what specific cell population secretes Wnts that modulate β-
catenin activity in liver homeostasis and LR is unknown. Wntless (Wls) encoding a multipass 
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transmembrane protein has been identified as a regulator for proper sorting and secretion of Wnts 
[108]. Deficiency in Wls leads to Wnt secretion defects and failure to activate β-catenin [93]. In 
order to study Wnt secretion from different hepatic populations, we generated cell specific Wls 
knockout mice that lack the ability of a specific cell population to secrete Wnt ligands. Wls 
conditional KO for liver epithelial cells (Wls-LKO), endothelial cells (Wls-EKO), macrophages 
including Kupffer cells (Wls-MKO) and stellate cells (Wls-SKO) were generated. Hepatic 
zonation and LR kinetics were analyzed in all animal models to elucidate the cellular source of 
Wnt ligands playing critical roles in these processes (Figure 10). 
 
 
Figure 10. Generation of cell specific Wls knockout 
Wls double floxed mice are bred with Cre transgenic mice driven by different cell specific promoters for hepatocytes, 
hepatic stellate cells (HSCs), macrophages (Mac) and endothelial cells (EC), to generate cell specific Wls knockouts. 
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Hepatic zonation and liver regeneration were analyzed in individual knockout models, to identify the cellular source of 
Wnt ligands playing important roles in these processes. 
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3.0  MATERIALS AND METHODS 
3.1 MICE AND BREEDING 
Homozygous Lrp5/6 double-floxed mice were reported recently [109]. To conditionally 
delete Lrp5 and Lrp6 from hepatocytes and cholangiocytes, homozygous Lrp5/6 double-floxed 
mice (Lrp5
flox/flox
Lrp6
flox/flox
) were bred with Cre transgenic mice driven by an albumin promoter 
(Albumin-Cre) (Jackson Laboratories, Bar Harbor, ME) [110]. The offspring carrying homozygous 
Lrp5 floxed alleles, a floxed Lrp6 allele and an albumin-Cre allele (Lrp5
flox/flox
Lrp6
flox/wt
Alb-Cre
+/-
) 
were then bred to homozygous Lrp5/6 double-floxed mice (Lrp5
flox/flox
Lrp6
flox/flox
). The mice with 
genotype Lrp5
flox/flox
Lrp6
flox/flox
Alb-Cre
+/-
 represent liver-specific Lrp5/6 KO or Lrp-LKO mice. 
Other genotypes Lrp5
flox/wt
; Lrp6
flox/wt
;
 
Alb-Cre
-/-
 & Lrp5
flox/flox
; Lrp6
flox/lwt
;
 
Alb-Cre
-/-
 & Lrp5
flox/wt
; 
Lrp6
flox/flox
;
 
Alb-Cre
-/-
 & Lrp5
flox/flox
; Lrp6
flox/flox
;
 
Alb-Cre
-/-
 were used as controls (Con). No 
phenotype was observed in Con. Genotyping was performed by polymerase chain reaction (PCR) 
analysis using genomic DNA isolated from a tail clipping. 
In order to generate liver-specific Wls KO, homozygous Wls floxed mice (Wls
flox/flox
) were 
bred with Albumin-Cre
+/-
 mice (Jackson Laboratories, Bar Harbor, ME) [110]. The offspring 
carrying floxed Wls allele and Albumin-Cre (Wls
flox/wt
; Alb-Cre
+/-
) were bred to homozygous Wls 
floxed mice (Wls
flox/flox
). Mice with genotype Wls
flox/flox
; Alb-Cre
+/-
 represent Wls-LKO mice. Mice 
with genotypes Wls
flox/flox
; Alb-Cre
-/-
 and Wls
flox/wt
; Alb-Cre
-/-
 were used as Con. 
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To generate liver specific Wnt5a KO mice, homozygous Wnt5a floxed mice (Wnt5a
flox/flox
) 
were bred with Albumin-Cre
+/-
 mice [110]. The offspring carrying floxed Wnt5a allele and 
Albumin-Cre (Wnt5a
flox/wt
; Alb-Cre
+/-
) were bred to homozygous Wnt5a floxed mice (Wnt5a
flox/flox
). 
Mice with genotype Wnt5a
flox/flox
; Alb-Cre
+/-
 represent Wnt5a-LKO mice. Mice with genotypes 
Wnt5a
flox/flox
; Alb-Cre
-/-
 and Wnt5a
flox/wt
; Alb-Cre
-/-
 were used as Con. 
To generate stellate cell-specific Wls KO mice, Wls
flox/flox
 mice were bred with GFAP-Cre
+/- 
mice
 
(Jackson Laboratories, Bar Harbor, ME) [111] using similar strategy as described above. 
Mice with genotype Wls
flox/flox
; GFAP-Cre
+/-
 represent Wls-SKO. Mice with genotypes Wls
flox/flox
; 
GFAP-Cre
-/-
 and Wls
flox/wt
; GFAP-Cre
-/-
 were used as Con. 
To generate macrophage-specific Wls KO mice, Wls
flox/flox
 mice were bred with Lyz2-Cre
+/- 
(also called LyzM-Cre) mice
 
(Jackson Laboratories, Bar Harbor, ME) [112] using similar strategy 
as described above. Mice with phenotype Wls
flox/flox
; Lyz2-Cre
+/-
 represent Wls-MKO. Mice with 
genotypes Wls
flox/flox
; Lyz2-Cre
-/-
 and Wls
flox/wt
; Lyz2-Cre
-/-
 were used as Con. 
To generate endothelial cell specific Wls knockout mice, Wls
flox/flox
 mice were bred to Tie2-
Cre
+/- 
mice
 
(Jackson Laboratories, Bar Harbor, ME) [113] in the same manner as above to obtain 
Wls
flox/flox
; Tie2-Cre
+/-
 mice. Since, no viable pups for Wls
flox/flox
; Tie2-Cre
+/-
 were obtained, mice 
with genotype Wls
flox/wt
; Tie2-Cre
+/-
 were used for experiments and mice with genotypes Wls
flox/flox
; 
Tie2-Cre
-/-
 and Wls
flox/wt
; Tie2-Cre
-/-
 were used as Con. 
Further, to generate viable endothelial cell specific Wls knockout mice, Wls
flox/flox
 mice 
were bred to VE-cadherin-CreER
T2 
mice [114] in the same manner as above. Mice with phenotype 
Wls
flox/flox
; VE-cadherin-CreER
T2+/-
 represent Wls-EKO. Mice with genotypes Wls
flox/flox
; VE-
cadherin-CreER
T2-/-
 and Wls
flox/wt
; VE-cadherin-CreER
T2-/-
 were used as Con.  
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3.2 TAMOXIFEN INJECTION 
Tamoxifen was injected to adult Wls-EKO and control mice in order to induce Cre 
recombinase activity. Tamoxifen (Sigma) was dissolved in corn oil (Sigma) to make the final 
concentration 50 mg/ml. Six- to eight-week old control and Wls-EKO mice were injected with 7.5 
mg tamoxifen every 48 hours, 3 injections in total, and the livers were harvested at one week, two 
weeks or four weeks after the last injection. 
3.3 MORPHOMETRIC ANALYSIS 
All experiments on mice were performed under the strict guidelines of the National 
Institutes of Health and the Institutional Animal Use and Care Committee at the University of 
Pittsburgh. Age- and sex-matched conditional KO and Con littermates were weighed and killed 
(n=3–5). Livers were isolated and the wet weights were recorded to calculate the liver weight to 
body weight ratio (LW/BW X100). The means for the 2 groups were compared for statistically 
significant differences by Student t test. 
3.4 PARTIAL HEPATECTOMY 
Twelve-week-old male Con or KO were subjected to partial hepatectomy (PH) [115]. Equal 
numbers of KO and Con mice were killed by cervical dislocation after Isoflurane anesthesia at 
different time points: 4 hours (n=3), 24 hours (n=3), 40 hours (n≥3), 3 days (n≥3), 4 days (n=3) 
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and 5 days (n=3) after PH. The regenerating livers were harvested and used for protein extraction, 
and paraffin embedding as described elsewhere [65, 68]. 
3.5 ACETAMINOPHEN LIVER TOXICITY AND MORTALITY 
Twelve-week-old Lrp-LKO mice (n=5) and Con mice (n=5) received an intraperitoneal 
injection of acetaminophen (600 mg/kg dissolved in 0.45% NaCl). Animals were sacrificed 24 
hours after acetaminophen administration. Blood samples were collected from orbital sinus, and 
serum alanine aminotransferases (ALT) and aspartate aminotransferase (AST) levels determined 
by automated methods at the University of Pittsburgh Medical Center Clinical Chemistry 
laboratory. 
3.6 PROTEIN EXTRACTION AND WESTERN BLOTS  
Whole-cell lysate preparation was performed using RIPA buffer (9.1 mM dibasic sodium 
phosphate, 1.7 mM monobasic sodium phosphate, 150mmol/L sodium chloride, 1% Nonidet P-40, 
0.5% sodium deoxycholate, 0.1% sodium dodecylsulfate [pH adjusted to 7.4]) containing fresh 
protease and phosphatase inhibitor cocktails (Sigma, St. Louis, MO) as described previously [65]. 
40-50 g of protein was resolved by sodium dodecyl sulfate–polyacrylamide gel electrophoresis 
analysis using the mini-PROTEIN 3 electrophoresis module assembly (Biorad, Hercules, CA) and 
transferred to immobilon-polyvinylidene difluoride membranes (Millipore, Billerica, MA). 
Proteins were detected by Super-Signal West Pico Chemiluminescent Substrate (Pierce, Rockford, 
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IL) and visualized by autoradiography.  
Primary antibodies used in this study were against β-catenin (BD Transduction); TCF4 
(Cell Signaling), Lrp5 (Cell Signaling), Lrp6 (Cell Signaling), Cyclin-D1 (Thermo Marker); -
catenin (Cell Signaling), E-cadherin (Santa Cruz Biotechnology), Regucalcin (Santa Cruz 
Biotechnology), Glutamine Synthetase (Santa Cruz Biotechnology), Cyp1a2 (Santa Cruz 
Biotechnology), Cyp2e1 (Millipore), Wls (Millipore), Actin (Chemicon); and GAPDH (Santa Cruz 
Biotechnology) at 1:1000. Horseradish-peroxidase-conjugated secondary antibodies (Chemicon) 
were used at 1:20,000 to 1:50,000 dilutions. 
3.7 HISTOLOGY AND IMMUNOHISTOHEMISTRY  
Liver sections from the age- and sex-matched KO and Con mice were analyzed by 
immunohistochemistry (IHC) for β-catenin (Santa Cruz Biotechnology), Glutamine Synthetase 
(Santa Cruz Biotechnology), Cyp1a2 (Santa Cruz Biotechnology), Cyp2e1 (Millipore) and PCNA 
(Santa Cruz Biotechnology) to determine their expression and/or localization using the indirect 
immunoperoxidase technique as described previously [116]. Briefly, 4 m paraffin sections were 
passed through xylene, graded ethanol, and rinsed in phosphate-buffered saline (PBS). 3% 
hydrogen peroxide (Sigma) was used to inactivated endogenous peroxide. Slides were microwaved 
in citrate buffer for 8 minutes and blocked in super block (ScyTek Laboratories) for 10 minutes 
followed by 1-hour incubation at room temperature in the primary antibody. After 3 washes with 
PBS, the sections were incubated in the secondary horseradish-peroxidase-conjugated antibody 
(Chemicon) for 30 min at room temperature and signal was detected using the ABC Elite kit 
(Vector Laboratories, Burlingame, CA) following the manufacturer’s instructions. Sections were 
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counterstained with Shandon (Thermo Scientific) for 1 minute and passed through the dehydration 
process followed by cover slipping and mounting using DPX (Fluka Labs, St. Louis, MO). Slides 
were viewed under an Axioskop 40 (Zeiss) upright research microscope and digital images were 
obtained by Nikon Coolpix camera.  
For proliferation assay, indirect IHC was performed for PCNA that recognizes cells in the 
cell cycle. The positive cells were counted in 3 low-power fields (200X) in 3 sections from 3 
different knockout or control livers. The average numbers of positive cells were compared and 
statistical assessment was made by the Student t test. A p value of less than 0.05 was considered 
significant.  
3.8 IMMUNOPRECIPITATION 
Five hundred μg of lysate in a 1-ml volume (in the presence of protease and phosphatase 
inhibitors) was precleared using appropriate control IgG together with 12 μl of protein A/G 
agarose for 30 min at 4°C (Santa Cruz Biotechnology). The supernatant obtained after 
centrifugation (1000 × g) at 4°C was incubated with primary antibody overnight at 4°C using end-
over-end rotation, followed by 20 μl of resuspended protein A/G agarose for 1 h. The pellets were 
collected by centrifugation (1000 × g) and washed four times for 5 min each with RIPA buffer at 
4°C. The pellets were resuspended in an equal volume of standard electrophoresis loading buffer 
with SDS and fresh β-mercaptoethanol and boiled for 5 min. 15 μl of the samples were resolved on 
ready gels. Antibodies used for immunoprecipitation were mouse anti-β-catenin (BD 
Transduction) and rabbit anti-TCF4 (Cell Signaling). 
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3.9 SEPARATION OF HEPATOCYTES, ENDOTHELIAL CELLS AND 
MACROPHAGES 
Mouse liver cells were isolated by 2-step collagenase perfusion [71]. Hepatocytes were 
isolated as a pellet after centrifugation (500rpm) for 5 minutes. The supernatant was centrifuged 
(1500 rpm) for 10 minutes, and the pellet containing mostly non-parenchymal cells (NPCs) was 
collected. Endothelial cell and macrophage positive selection from NPCs was performed using 
QuadroMACS column separation Kit (Miltenyi Biotech, Cambridge, MA). Anti-mouse CD31, 
anti-mouse F4/80 antibody (Biolegend, San Diego, CA) and specific microbeads were used 
according to the manufacture’s instruction. After the column separation, RNA was extracted from 
the cell pellet, and cytospin was performed with the cell suspension. Cells were centrifuged at 500 
rpm for 5 minutes on glass slides followed by fixation with 4% paraformaldehyde for 10 minutes 
when used for immunofluorescence staining. 
3.10 SEPARATION OF HEPATIC STELLATE CELLS 
HSCs were isolated from Con mice and Wls-SKO as described [117, 118]. Briefly, livers were 
digested with collagenase- and protease-containing HBSS. Cells were suspended and incubate with 
collagenase and DNase at 37
0
C for 45 min. The suspension was filtered through nylon mesh. The 
filtrate was centrifuged (50g) 3-4 times for 1 min to remove hepatocytes and cell debris, and the 
supernatant was collected and centrifuged (1400g) for 7 min. The pellet containing NPCs was 
suspended in HBSS, and after purification via Nycodenz gradient centrifugation, HSCs were 
suspended (1 × 10
6
 cells/ml) in DMEM containing 10% FBS, 10% horse serum. Cells were seeded 
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on gelatin (0.1% in PBS)-coated plates at a density of 0.5×10
6
/cm
2
. Twenty minutes later, loosely 
adherent HSCs were harvested and RNA was harvested.  
3.11 IMMUNOFLUORESCENCE STAINING 
The staining was done using the protocol described before [65]. Briefly, cells were blocked 
in 2% bovine serum albumin in PBS for 45 min at room temperature. Primary antibody, rat anti-
mouse F4/80 antibody (AbD Serotec, Raleigh, NC) at 1:100 dilution, was added to sections for 1 h 
at room temperature. After being washed, the fluorescently tagged secondary antibodies were 
applied to the sections for 1 h at room temperature. After three washes with PBS, the nuclei were 
counterstained using 0.001% Hoechst dye (bis-benzimide). The slides were coverslipped using 
gelvatol.  
3.12 RNA ISOLATION AND QUANTITATIVE POLYMERASE CHAIN REACTION  
Cellular RNA was obtained by micro RNA isolation kit (Ambion). Total RNA was reverse-
transcribed after DNase treatment using the TURBO DNAse Kit (Ambion) as per the 
manufacturer's instructions. The RNA was used for quantitative polymerase chain reaction (q-
PCR) analysis as described elsewhere [119]. The comparative delta Ct (ΔCT) method was used for 
analysis of the data, and calculations were made with the StepOne software (Applied Biosystems, 
Grand Island, NY). The primers used in the study are listed (Table. 1). 
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Table 1. Primer sequences used for q-PCR 
Gene Forward primer Reverse primer 
Alb tgacccagtgttgtgcagag ttctccttcacaccatcaagc 
CD68 gacacttcgggccatgtt gaggaggaccaggccaat 
Lyz gaatggaatggctggctact cgtgctgagctaaacacacc 
Tie2 cataggaggaaacctgttcacc gcccccacttctgagctt 
Vegfr2 cagtggtactggcagctagaag acaagcatacgggcttgttt 
Gfap tcgagatcgccacctacag gtctgtacaggaatggtgatgc 
Desmin gcgtgacaacctgatagacg tggatttcctcctgtagtttgg 
Gapdh acccagaagactgtggatgg cacattgggggtaggaacac 
Wls cccagccatgagcaaagt gcatgaggaacttgaacctga 
GS ctcgctctcctgacctgttc ttcaagtgggaacttgctga 
Cyp1a2 cctggactgactcccacaac aacgccatctgtaccactga 
Cyp2e1 ccaccagcacaactctgagata cccaataaccctgtcaatttctt 
Wnt1 atccatctctcccacctcctac gaatctttctctcaccctctgg 
Wnt2 tctgtctatcttgggcattctg ttccttcgctatgtgatgtttc 
Wnt2b accttcctctaccctcaatcct tcactcagcctcctaaatccat 
Wnt3 gtctgctaatgctggcttgac taggaagggatgggaggtgt 
Wnt3a tcggcgatggtggtagagaaac tcgcagaagttgggtgagg 
Wnt4 agaactggagaagtgtggctgt aaaggactgtgagaaggctacg 
Wnt5a gtcctttgagatgggtggtatc acctctgggttagggagtgtct 
Wnt5b tgtcagttgtatcaggagcaca gtgaaggcagtctctcggcta 
Wnt6 tttacaccagcccacgaaag actcacccatccatcccagta 
Wnt7a ggatgctcacagggaaagaac gcaggaaacccagaataccc 
Wnt7b gctccttcctactcgctctgt ggtccctttgtggttcacttt 
Wnt8a acggtggaattgtcctgagcatg gatggcagcagagcggatgg 
Wnt8b gtttgcttgggaccgttg tccatttcgggagtcatca 
Wnt9a atggtgtgtctggctcctg cagtggcttcattggtagtgct 
Wnt9b gggtgtgtgtggtgacaatct ggtccttgcttcctctcttg 
Wnt10a tcctgttcttcctactgctgct acgcacacacacctccatc 
Wnt10b ccactacagcccagaacctc ggagagaccctttcaacaactg 
Wnt11 ccctggaaacgaagtgtaaatg aggtagcgggtcttgaggtc 
Wnt16 gctgtaacctcctctgctgtg gtggacatcggtcatactttca 
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3.13 ENZYME-LINKED IMMUNOSORBENT ASSAY  
48 hours after PH, liver was perfused and hepatocytes were cultured for 24 hours. Conditioned 
medium was collected and concentrated by centrifugal filter devices (Millipore). Wnt5a level was 
measured by using the mouse Wnt5a enzyme-linked immunosorbent assay (ELISA) kit 
(CUSABIO). Experiments were performed according to the manufacturer's instructions. In brief, 
standard and samples were loaded onto 96-well microplates pre-coated with antibody specific for 
Wnt5a, and incubated for 2 hours at 37°C. Each well was aspirated and then the plate was 
incubated with biotin-conjugated antibody specific for Wnt5a for 1 hour at 37°C. After washing, 
avidin conjugated Horseradish Peroxidase (HRP) was added to the wells and incubated for 1 hour 
at 37°C. Following a wash to remove any unbound avidin-enzyme reagent, a substrate solution 
was added to the wells and incubated for 15-30 minutes at 37°C to induce a color reaction. The 
reaction was stop by adding Stop Solution to each well. Optical density of each well was 
determined by microplate reader at wavelength 450 nm.  
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4.0  RESULT  
4.1 RESULT (AIM1): BETA-CATENIN ACTIVATION IN LIVER IS WNT-
SIGNALING DEPENDENT 
To address to what extent -catenin activation is Wnt-signaling dependent in liver 
homeostasis and during liver regeneration (LR), we generated liver-specific Lrp5/6 null mice (Lrp-
LKO) where only Wnt-signaling is abolished, while Wnt-independent signaling remains intact, and 
compared them with liver-specific -catenin null mice (-catenin-LKO). 
4.1.1 Generation and characterization of conditional Lrp5/6 null mice  
After strategic breeding, liver-specific Lrp5/6 null mice (Lrp-LKO) were generated [120]. 
Genotyping was performed by PCR (Figure 11A), using primer P1 and P3 as described previously 
[109]. Livers from Lrp-LKO exhibited a significant decrease in Lrp5 and Lrp6 protein compared to 
control mice (Con) (Figure 11A). Eight-month-old Lrp-LKO and Con mice had comparable and 
normal levels of serum AST, ALT and albumin (data not shown). While total bilirubin was within 
normal range, average in controls was 0.26 mg/dl (n=5) as compared to 0.5 mg/dl (n=5) in Lrp-
LKO (p=0.009). Lrp-LKO also displayed smaller livers and LW/BW ratio was significantly lower 
in Lrp-LKO compared to Con (Figure 11B). To address the discrepancy in size, we assessed 
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hepatocytes in S-phase by PCNA immunohistochemistry (IHC). Lrp-LKO livers had significantly 
less PCNA positive cells at baseline (Figure 11C, 11D). Concomitantly, lower Cyclin-D1 
expression was also evident in KO by western blots (WB) (Figure 11E). Intriguingly, all the above 
observations were similar to -catenin-LKO mice [49].  
4.1.2 β-Catenin at adherens junctions in the Lrp-LKO livers at baseline 
Next, we assessed -catenin levels and levels of other key components at adherens 
junctions in the Lrp-LKO livers [120]. WB shows Lrp-LKO and Con to have comparable levels of 
-catenin, -catenin and E-cadherin (Figure 11E).  
4.1.3 Disruption of metabolic zonation in conditional Lrp5/6 null mice 
Next, we assessed β-catenin localization by IHC in Con and Lrp-LKO livers [120]. Con 
livers show predominantly membranous β-catenin except in pericentral hepatocytes where there 
was enhanced cytosolic labeling as well (Figure 11F). However in Lrp-LKO, cytosolic β-catenin 
localization in pericentral hepatocytes was notably lacking with occasional periportal hepatocyte 
showing some cytoplasmic staining (Figure 11F). Lrp-LKO livers also showed notably low protein 
expression of multiple downstream targets of β-catenin, such as Regucalcin, GS, Cyp1a2 and 
Cyp2e1 (Figure 11E). IHC also showed loss of pericentral expression of GS, Cyp2e1 and Cyp1a2 
in Lrp-LKO livers (Figure 12A).  
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Figure 11. Successful deletion of Lrp5 and Lrp6 in liver leads to alterations in downstream β-catenin signaling 
(*p<0.05, **p<0.01) 
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A. Representative PCR (upper panel) shows genotype of mice for identifying Lrp-LKO with genotype Lrp5
flox/flox
; 
Lrp6
flox/flox 
; Cre
+/-
 (lane 1). Mice with other genotypes (lane 2-5) were used as Con. Representative WB (lower panel) 
shows a dramatic decrease in Lrp5 and Lrp6 in the tissue lysates from the Lrp-LKO livers.  
B. Decreased LW/BW ratio in 8-month old Lrp-LKO. This difference was around 20% in both males and females and 
significant.  
C. IHC for PCNA shows an occasional positive hepatocyte (arrow) in a representative section from Con liver at 
baseline, while none were detected in Lrp-LKO.  
D. Quantification of PCNA staining shows significantly fewer positive cells in Lrp-LKO.  
E. Representative WB shows no change in total levels of β-catenin, γ-catenin and E-cadherin in Lrp-LKO livers as 
compared to Con. However several downstream targets of β-catenin were downregulated in Lrp- LKO livers. 
Prolonged exposure of WB film enabled us to observe baseline Cyclin-D1 in Con, which was notably reduced in Lrp-
LKO livers.  
F. IHC for β-catenin shows predominantly membranous localization in both Lrp-LKO and Con livers. However, in 
Con, cytosolic localization of β-catenin was seen in hepatocytes around central vein (CV) and not portal triads (PT). 
Lrp-LKO show absence of cytosolic β-catenin around CV with a few hepatocytes around PT showing some 
cytoplasmic localization. (left panel Con and KO-100x; right panel Con and KO-200x).  
 
 
The functional loss of Cyp1a2 and Cyp2e1 was further addressed by acetaminophen 
(APAP) toxicity study [120]. Cyp1a2 and Cyp2e1 metabolize APAP to a toxic metabolite, N-
acetyl-p-benzo-quinone imine (NAPQI), which is highly reactive and causes liver cell necrosis 
through glutathione depletion [121, 122]. -Catenin-LKO mice are protected from APAP overdose 
due to absent Cyp2e1 and Cyp1a2 [48, 49]. Likewise Lrp-LKO when administered intra-peritoneal 
injection of APAP (600mg/kg), showed significantly lower serum AST and ALT levels as 
compared to Con (Figure 12B). Therefore, despite normal β-catenin levels in Lrp-LKO, ablation of 
Lrp5/6 to disrupt Wnt signaling impaired β-catenin activity and zonation. 
 46 
 
Figure 12. Loss of Lrp5/6 in liver compromises pericentral zonation 
A. IHC shows normal pericentral expression of GS, Cyp1a2 and Cyp2e1 in Con livers, while absence of these proteins 
is observed in littermate Lrp-LKO livers.  
B. When injected with lethal dose of APAP (600 mg/kg body weight), Lrp-LKO showed significantly lower ALT and 
AST levels than Con after 24 hours (*p<0.05). 
 
 
 47 
4.1.4 Retarded liver regeneration in Lrp-LKO mice after partial hepatectomy 
Next, Lrp-LKO and Con were subjected to PH. As expected, Con mice showed abundant 
hepatocytes in S-phase at 40 and 72 hours after PH with decline at later time-points (Figure 13A, 
13B) [120]. Intriguingly, Lrp-LKO livers exhibited significantly fewer PCNA-positive hepatocytes 
at both 40 and 72 hours, although more PCNA-positive hepatocytes were observed at 72 than 40 
hours (Figure 13A, 13B). In addition, numbers of mitotic figures as assessed by analysis of H&E 
images from Lrp-LKO and Con showed a notably lower mitosis in hepatocytes in the former at 72 
hours (Figure 14A, 14B). -Catenin target Cyclin-D1 that regulates G1-S phase transition during 
LR [123] was notably lower in Lrp-LKO at 40 hours with progressive increase at 72 hours 
although it was still lower than Con (Figure 13D).  
Next, we wanted to address if -catenin could be activated by alternate signals in Lrp-LKO 
than Con after PH. Intriguingly, no differences in Y654-, S552- or S675--catenin were evident 
between the Lrp-LKO and Con at 40 or 72 hours after PH (Figure 13C).  
Since β-catenin binding to TCF4 precedes Cyclin-D1 expression after PH [49, 71], we 
assessed their association by immunoprecipitation at 4 hours after PH [120]. TCF4-β-catenin 
complex was observed in Con but absent in Lrp-LKO (Figure 13E).  
Taken together, these data suggest that Lrp-LKO phenocopy β-catenin-LKO after PH, 
thereby indicating that only Wnt signaling is responsible for β-catenin activation during LR after 
PH. 
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Figure 13.  Abolishing Wnt/β-catenin signaling through Lrp5/6 ablation in liver impairs LR after PH 
 49 
A. IHC for PCNA identifies several hepatocytes in S-phase at 40 and 72 hours after PH, while only a few trailing 
hepatocytes were PCNA-positive at 96 and 120 hours. In contrast, Lrp-LKO showed dramatically fewer PCNA-
positive hepatocytes at 40 hours with an increase at 72 hours. Like Con, only a few PCNA positive hepatocytes were 
detected at later times in Lrp-LKO (200x).  
B. PCNA quantification shows a gradual increase in positive hepatocytes in Lrp-LKO from 40 to 72 hours although 
these are lower than Con at both times (**p<0.01).  
C. Representative WB shows comparable levels of S675-β-catenin, S552-β-catenin, Y654-β-catenin and total β-
catenin in Con and Lrp-LKO livers after PH.  
D. WB shows low protein expression of Cyclin-D1 after PH in Lrp-LKO compared to Con at both 40 and 72 hours 
although its levels increase in Lrp-LKO at 72 hours.  
E. Representative WB shows β-catenin and TCF4 association at 4 hours after PH in Con and not Lrp-LKO livers by 
immunoprecipitation studies. Immunoprecipitation studies were performed by pull down of either β-catenin or TCF4. 
Respective input controls are included in analysis as well. 
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Figure 14. Mitotic figures show impaired liver regeneration in Lrp-LKO 
A. Mitotic figures of Con and Lrp-LKO at 40, 72 and 96 hours after PH.  
B. Quantification of mitotic figures shows a significantly lower number in Lrp-LKO as compared to Con at 72 hours 
after PH. (**p<0.01) 
 51 
4.2 RESULT (AIM2): THE CELLULAR SOURCE OF WNT LIGANDS 
Our work demonstrated that Wnt-signaling is the predominant pathway that regulates β-
catenin effects in both liver homeostasis and during liver regeneration (LR) [120]. We hence next 
aimed to investigate the cellular source of Wnt ligands in the liver. By isolating major hepatic cell 
populations, we analyzed cell specific Wnt expression in liver homeostasis and during LR. By 
genetic manipulation of Wntless (Wls), which is specific and necessary for Wnt secretion [124], we 
generated multiple cell-specific Wls deletion mice, which lack the ability of a specific hepatic cell 
population to secrete Wnt ligands, and analyzed their hepatic zonation and LR kinetics, to 
elucidate the role of different liver cell types in Wnt secretion and β-catenin activation. 
 
4.2.1 Wnt expression in individual hepatic cell populations in liver homeostasis and 
regeneration 
Our lab has previously shown that major cell types in the liver express various Wnt ligands 
in normal liver [82]. In order to get deeper insight into the role of different cell types in Wnt 
secretion and address the cellular source of Wnt proteins in the liver, we isolated different liver cell 
types after collagenase perfusion, and analyzed Wnt expression at baseline and after partial 
hepatectomy (PH), to address the potential cellular source of Wnt ligands in liver homeostasis and 
during LR. 
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4.2.1.1 Wnt expression profile in individual liver cell types at baseline 
Different liver cell populations, including hepatocytes, endothelial cells, macrophages and 
stellate cells, were isolated from two-months-old male mice as described in the methods. The high 
purity of isolated cells was confirmed by quantitative PCR (q-PCR) using primers for cell specific 
markers (Figure 15).  
The Wnt expression profile in hepatocytes, endothelial cells and macrophages was 
determined by q-PCR (Figure 16). The expression of eight out of the nineteen Wnts was detectable 
in hepatocytes, and eleven out of nineteen Wnts were detectable in endothelial cells, and ten out of 
nineteen in macrophages. Among the Wnts that can be detected (Figure 16), the expression pattern 
appears to be distinct in individual cell types. Wnt2 and Wnt2b were highly expressed in 
endothelial cells and macrophages. Some Wnt ligands, such as Wnt4, Wnt9b and Wnt16 were 
mainly expressed in endothelial cells, while hepatocytes have more abundant Wnt5a and Wnt5b 
expression.  
Previous studies have demonstrated various roles of Wnt ligands in different aspects of 
liver biology. Wnt2 has been shown to be a pro-proliferative signal that is induced after PH to 
trigger LR [102]; Wnt2b signaling positively regulates liver specification during liver development 
[125]; Wnt4 upregulation has been shown to activate stellate cells [126]. While Wnt5a activate 
noncanonical β-catenin-independent pathways [127], it is expressed in mature hepatocytes and 
cholangiocytes [82], but the physiological functions of Wnt5a in liver are not clear. The different 
expression pattern of Wnt ligands in individual hepatic cell populations might be crucial for 
maintaining liver homeostasis, or might be related to the functions of specific cell populations in 
response to PH or liver injuries.  
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Figure 15. Q-PCR analysis of cell specific markers in individual hepatic cell populations 
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Four major hepatic cell populations were isolated with high purity. The cell specific marker expression was 
determined by q-PCR. Relative expression levels were normalized to Gapdh. HC, hepatocytes; EC, endothelial cells; 
Mp, macrophages; SC, stellate cells.  
 
Figure 16. Wnt expression analysis in individual cell populations at baseline 
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Hepatocytes (HC), endothelial cells (EC) and macrophages (Mp) were isolated from normal mouse liver, and Wnt 
expression in individual cell populations was determined by q-PCR. The expression of Wnt was normalized to Gapdh. 
 
 
 
4.2.1.2 Wnt expression profile in individual liver cell types during liver regeneration 
Next, Wnt expression was examined in different cell populations after PH. Fold changes of 
Wnt expression 12 hours after PH versus before PH was analyzed in hepatocytes, endothelial cells 
and macrophages (Figure 17). The Wnt expression pattern differed in individual cell populations; 
notably, Wnt2 and Wnt9b expression were dramatically induced in both endothelial cells and 
macrophages after PH, but the increase was moderate in hepatocytes (Figure 17). There was a 45-
fold induction of Wnt2 expression and a 16-fold increase of Wnt9b expression in endothelial cells. 
In macrophages, the induction of Wnt2 and Wnt9b was also dramatic; while in hepatocytes, the 
increase was marginal (Table 2). Wnt2 and Wnt9b expression in resting and regenerating livers 
(Figure 18) further confirmed this finding. 
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Figure 17. Wnt expression in individual cell populations after PH 
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Wnt expression was analyzed in hepatocytes (A), endothelial cells (B), and macrophages (C) 12 hours after 
PH. The expression levels at 12 hours after PH were normalized to the levels prior to PH (pre).  
HC, Hepatocytes; EC, Endothelial cell; Mp, Macrophages. 
 
 
Table 2. Ranking of fold changes of Wnt expression after PH in individual cell populations 
Endothelial cell Macrophage 
Ranking Gene Fold change Ranking Gene Fold change 
1 Wnt2 45 1 Wnt2 9.8 
2 Wnt9b 16 2 Wnt9b 5.2 
3 Wnt4 7.3 3 Wnt11 3.2 
4 Wnt5a 4.4 4 Wnt4 2.3 
5 Wnt11 3.7 5 Wnt16 2.2 
6 Wnt2b 3.7 6 Wnt2b 2.2 
7 Wnt10b 3.3 7 Wnt9a 1.75 
8 Wnt9a 3.2 8 Wnt6 1.33 
9 Wnt10a 2.9 9 Wnt3 0.57 
10 Wnt5b 2.4 10 Wnt5a 0.46 
11 Wnt16 2.4 11 Wnt5b 0.38 
  12 Wnt3 1.89 
     
Hepatocyte 
Ranking Gene Fold change 
1 Wnt2 2.5 
2 Wnt9b 2.3 
3 Wnt5b 2 
4 Wnt2b 2 
5 Wnt5a 1.34 
6 Wnt16 1.33 
7 Wnt9a 1.3 
8 Wnt4 1.1 
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Figure 18. Wnt2 and Wnt9b expression in individual cell populations before and after PH 
Wnt2 (A) and Wnt9b (B) expression was analyzed in different cell types before and 12 hours after PH. HC, 
Hepatocytes; EC, Endothelial cell; Mp, Macrophages. 
 
 
Wnt2 has been shown to be an autocrine growth factor in liver sinusoidal endothelial cells 
(LSECs). Wnt2 induces endothelial cell proliferation and differentiation by stimulating VEGF 
signaling [128]. After PH, Wnt2 is secreted by LSECs to trigger LR [102]. Our finding that Wnt2 
expression is highly upregulated in endothelial cells after PH further confirms LSECs being a 
source of Wnt2 during LR. More importantly, our finding that Wnt2 is significantly induced in 
macrophages after PH suggests a potential role of macrophages being a source of stimulatory Wnts 
during LR. We also found that the expression of Wnt9b was dramatically induced in endothelial 
cells and macrophages after PH; however, the function of Wnt9b in liver biology is not well 
understood.   
Taken together, the Wnt expression profile after PH indicates that endothelial cells and 
macrophages could both be the source of Wnt ligands in response to PH, while hepatocytes might 
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not play an important role. However, the q-PCR analysis only indicates the Wnt expression but not 
protein secretion, and therefore, needs to be validated in the context of Wnt secretion. 
 
 
4.2.2 The role of liver epithelial cells in Wnt secretion 
Q-PCR analysis of Wnt expression suggests individual hepatic cell populations might have 
different roles in Wnt secretion. To further study Wnt protein secretion, we utilized Wls-floxed 
mice. Wntless (Wls) encodes a multipass transmembrane protein that is specific and necessary for 
Wnt transport from Golgi to the membrane for secretion [85]. In order to fully elucidate the 
cellular source of Wnt proteins directing β-catenin activity for zonation and LR, we generated cell 
type specific Wls knockout mice that lack the ability of a specific cell population to secrete Wnts. 
Hepatocyte and cholangiocyte specific (or liver-specific) Wls knockout mice (Wls-LKO) were first 
generated to address the role of liver epithelial cells in Wnt secretion.  
4.2.2.1 Generation and baseline characterization of liver-specific Wls knockout mice 
Hepatocyte and cholangiocyte specific (or liver-specific) Wls KO (Wls-LKO) were 
generated by interbreeding Albumin-Cre and Wls-floxed mice. PCR confirmed the concomitant 
presence of floxed allele and cre-recombinase in Wls-LKO (Figure 19A) using primers P2 and P4 
as described previously [94]. WB from Wls-LKO liver lysates shows less Wls relative to Con 
(Figure 19B). However, appreciable Wls persisted in Wls-LKO suggesting that other non-
parenchymal cells also express Wls, and which would not be affected by Albumin-Cre. Indeed, cell 
fractionation into parenchymal and non-parenchymal cells by percoll gradient after collagenase 
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perfusion showed notably higher Wls expression in the non-parenchymal cell compartment (data 
not shown). 
Eight-month-old Wls-LKO mice had comparable and normal levels of serum AST, ALT, 
bilirubin, and albumin levels to Con (data not shown). Wls-LKO showed marginally bigger livers 
than Con (Figure 19C), although the difference was not statistically significant. Baseline 
proliferation examined by IHC for PCNA did not reveal any differences (Figure 19D, 19E). 
4.2.2.2 Normal adherens junctions and hepatic zonation in Wls-LKO mice 
Next, we investigated changes in β-catenin, its downstream signaling and junctional 
proteins in Wls-LKO mice. β-Catenin, γ-catenin and E-cadherin were unchanged in Wls-LKO 
(Figure 19F). The expression of the downstream targets of β-catenin signaling was comparable 
between Wls-LKO and Con (Figure 19F). IHC for pericentral expression of β-catenin targets 
showed no differences in staining for GS, Cyp1a2 and Cyp2e1 between Wls-LKO and Con (Figure 
20A). Therefore, blocking Wnt secretion from hepatocytes or cholangiocytes does not affect 
regulation of zonation by β-catenin signaling in hepatocytes. 
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Figure 19. Successful deletion of Wls in Wls-LKO mice 
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A. Representative PCR shows genotype of mice for identifying the Wls
flox/flox 
; Albumin-Cre+/- (Wls-LKO) (lane 3). 
Mice with genotype Wls
flox/wt 
; Albumin-Cre-/- & Wls
flox/flox
 ;Albumin-Cre-/- (lanes 2 & 4) were used as Con.  
B. WB shows a modest decrease in Wls in liver of Wls-LKO compared to Con.  
C. Higher LW/BW ratio in 8-month old Wls-LKO as compared to Con although difference was not significant.  
D. IHC shows occasional PCNA-positive hepatocyte in Con and Wls-LKO liver (200X).  
E. Quantification of PCNA staining (200X) shows comparable number of positive hepatocytes between Con and Wls-
LKO.  
F. Representative WB shows comparable expression of β-catenin, relevant junctional components and β-catenin 
downstream, targets in Wls-LKO and Con livers. Prolonged exposure of WB film enabled us to observe baseline 
Cyclin-D1 in Wls-LKO and Con, which was comparable in the two groups. 
 
 
4.2.2.3 Normal initiation of liver regeneration in Wls-LKO mice 
The role of hepatocyte and cholangiocyte-derived Wnt proteins in LR was examined next 
by subjecting the Wls-LKO and Con to PH. Comparably higher numbers of PCNA-positive 
hepatocytes were observed in Wls-LKO and Con mice at 40 hours post-PH (Figure 20B). 
Quantification of PCNA staining showed no significant differences (Figure 20C). Likewise, Wls-
LKO had comparable Cyclin-D1 levels to Con at 40 hours (Figure 20D). Therefore, lack of any 
differences in regeneration kinetics at early time points after PH indicates that β-catenin activation 
during LR is not dependent on hepatocyte- or cholangiocyte-derived Wnts. 
 
 63 
 
Figure 20. Ablation of Wls in liver epithelial cells has no effect on hepatic zonation or initiation of LR 
A. IHC for GS, Cyp1a2 and Cyp2e1 in Con and Wls-LKO shows normal pericentral localization in both groups 
(100x).  
B. PCNA IHC shows comparable numbers of PCNA-positive hepatocytes in Con and Wls-LKO livers at 40 hours after 
PH (200X). 
C. Quantification of PCNA staining confirms similar numbers of PCNA-positive hepatocytes in Con and Wls-LKO at 
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40 hours after PH. 
D. Representative WB shows comparable Cyclin-D1 expression at 40 hours after PH in both Con and Wls-LKO livers. 
 
4.2.2.4 Continuous proliferation in Wls-LKO at late times after PH 
Temporarily enhanced LR in Wls-LKO after PH 
LR kinetics were further analyzed at later time points after PH, including 3 to 14 days after 
PH. PCNA staining showed comparably higher numbers of positive hepatocytes at 3 days after PH 
(Figure 21A). Intriguingly, 4 days after PH, when LR has already been attenuated in the Con livers 
as suggested by low numbers of PCNA positive cells, considerable amounts of proliferating cells 
were present in the Wls-LKO (Figure 21A). However, 5 days after PH, no differences in the 
number of positive cells were observed. At day 14, LR was completely terminated in both Con and 
Wls-LKO (Figure 21A). Quantification of PCNA staining showed a significantly higher number of 
proliferating cells in Wls-LKO 4 days after PH, with no differences after day 5 (Figure 21B). 
Consistently, WB showed higher levels of Cyclin-D1 in Wls-LKO at 4 days after PH, but the level 
went down at day 5 (Figure 21C). Immunoprecipitation showed enhanced β-catenin/TCF4 binding 
in the knockout at both 40 hours and 3 days after PH, suggesting that there was a delay in the 
termination of active β-catenin signaling in the Wls-LKO (Figure 21D). 
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Figure 21. Temporarily enhanced LR in Wls-LKO at later times after PH 
A. IHC for PCNA shows comparably high numbers of positive cells at 3 days after PH, a notably higher number of 
positive cells in Wls-LKO 4 days after PH, and comparably low numbers of positive cells at 5 days and 14 days after 
PH (200X). 
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B. Quantification of PCNA staining confirms significantly higher number of positive cells in Wls-LKO 4 days after 
PH (*p<0.05). 
C. Representative WB shows higher Cyclin-D1 expression at 4 days after PH in Wls-LKO livers. 
D. Immunoprecipitation shows enhanced β-catenin and TCF4 binding in Wls-LKO at 40 hours and 3 days after PH. 
 
Induction of Wnt5a signaling pathway at later time points after PH 
Given the fact that Wls-LKO had enhanced LR at late time points after PH and a delay in 
the termination of active β-catenin signaling, we hypothesized that hepatocytes might be able to 
secrete some inhibitory Wnt ligands involved in the termination of LR, while hepatocytes of Wls-
LKO were not capable of Wnt secretion, leading to a delay in the termination of LR. Wnt5a is a 
classic non-canonical Wnt ligand that has been shown to have an antagonistic role on Wnt/β-
catenin signaling [33-37]. Unpublished data from our lab also showed that Wnt5a can inhibit β-
catenin signaling in both primary hepatocytes and hepatoma cell lines, therefore we further 
examined Wnt5a signaling using Wls-LKO (Figure 22). WB with total liver lysates showed an 
induction of Wnt5a expression at 40 hours after PH (Figure 22A). At day 3, there were much less 
Wnt5a proteins in the Wls-LKO compared with Con, so as receptor Ror2. However, no obvious 
difference was observed at day 4. In order to address the role of hepatocytes in Wnt5a secretion 
during LR, primary hepatocytes from hepatectomized Con and Wls-LKO were cultured and the 
conditioned medium were collected 24 hours later. ELISA was performed to measure Wnt5a 
concentration in the conditioned medium. As expected, Wnt5a concentration in the Con 
conditioned medium was 2.5 fold higher than in the Wls-LKO medium (Figure 22B). Therefore, 
our experiments suggest that there is an induction of Wnt5a signaling after PH, which might be 
involved in the termination of LR. Hepatocytes from Con livers can secrete Wnt5a after PH, while 
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the hepatocytes from Wls-LKO have a defect in Wnt5a secretion, which might be the cause of 
enhanced LR in Wls-LKO. 
 
Figure 22. Defect of Wnt5a secretion from hepatocytes in the Wls-LKO 
A. WB shows induction of Wnt5a expression in the Con livers 40 hours after PH. At 3 days after PH, there is much 
less Wnt5a proteins in Wls-LKO compared with Con, so as Ror2.  
B. ELISA was performed to measure Wnt5a concentration in the conditioned medium. Wnt5a concentration in the 
Con medium is 2.5 fold higher than in the Wls-LKO medium.  
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Generation of liver specific Wnt5a knockout mice 
Our lab has shown that Wnt5a inhibited primary hepatocyte and HepG2 cell proliferation 
by suppressing β-Catenin signaling (unpublished data). Next we generated hepatocyte and 
cholangiocyte specific (or liver specific) Wnt5a knockout mice (Wnt5a-LKO) to elucidate the 
function of Wnt5a in vivo. Wnt5a-LKO were generated by interbreeding Albumin-Cre and Wnt5a-
floxed mice [129]. PCR confirmed the concomitant presence of floxed allele and cre-recombinase 
in Wnt5a-LKO (Figure 23A). WB from Wnt5a-LKO liver lysates shows less Wnt5a expression 
relative to Con (Figure 23B). Eight-month-old Wnt5a-LKO mice had comparable and normal 
levels of serum AST, ALT, bilirubin, and albumin levels to Con (data not shown). Wnt5a-LKO 
showed normal liver size similar to Con (Figure 23C). Baseline proliferation examined by IHC for 
PCNA did not reveal any differences (Figure 23D, 23E). β-Catenin and its downstream target 
Cyclin-D1 were unchanged in Wnt5a-LKO (Figure 23F). IHC for pericentral expression of β-
catenin targets showed no differences in staining for GS, Cyp1a2 and Cyp2e1 between Wnt5a-
LKO and Con (Figure 23G). Therefore, hepatocyte or cholangiocyte specific Wnt5a knockout 
mice display no alteration in β-Catenin signaling pathway at baseline. 
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Figure 23. Baseline characterization of Wnt5a-LKO mice 
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A. Representative PCR shows genotype of mice for identifying the Wnt5a
flox/flox 
; Albumin-Cre+/- (Wnt5a-LKO) (lane 
1). Mice with genotype Wnt5a
flox/flox
; Albumin-Cre-/- &Wnt5a
flox/wt 
; Albumin-Cre-/-  (lanes 3 & 4) were used as Con.  
B. WB shows a modest decrease in Wnt5a expression in livers of Wnt5a-LKO compared to Con.  
C. Normal LW/BW ratio in 8-month old Wnt5a-LKO as compared to Con.  
D. IHC shows occasional PCNA-positive hepatocyte in Con and Wnt5a-LKO liver (200X).  
E. Quantification of PCNA staining (200X) shows no difference in the number of positive hepatocytes between Con 
and Wnt5a-LKO.  
F. Representative WB shows comparable expression of β-catenin and Cyclin-D1 in Wnt5a-LKO and Con livers.  
G. IHC for GS, Cyp1a2 and Cyp2e1 shows normal zonation in Wnt5a-LKO livers. 
 
Liver specific Wnt5a knockout mice have normal LR kinetics 
Next, to address the role of Wnt5a in LR, Wnt5a-LKO and Con mice were subjected to PH. 
PCNA staining at different time points after PH did not reveal any differences in LR kinetics 
between Con and Wnt5a-LKO (Figure 24A, 24B). WB also showed comparable Cyclin-D1 levels 
at all the time points (Figure 24C). Therefore, deletion of Wnt5a in liver epithelial cells appears to 
have no notable effect on LR. To understand the reason for the lack of phenotype, we further 
investigated the Wnt5a expression pattern during LR in both Con and Wnt5a-LKO. Q-PCR 
analysis with total liver tissue showed that there were mild but significant differences in Wnt5a 
expression between Con and Wnt5a-LKO at baseline and early time points after PH, while no 
differences at the late time points (Figure 24D). Therefore, it is likely that liver epithelial cells are 
not the only source of Wnt5a. Other cell populations can also secrete Wnt5a during LR to 
compensate for the loss of epithelial cell derived Wnt5a. Other signaling pathways involved in the 
termination of LR, such as TGF-β [75, 76], ILK [79] and GPC3 [80, 81], might also be activated to 
ensure the proper termination of LR in the Wnt5a-LKO. 
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Figure 24. Ablation of Wnt5a in liver epithelial cells has no effect on liver regeneration 
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A. PCNA IHC shows comparable numbers of positively cells at all the time points after PH (200X). 
B. Quantification of PCNA staining reveals no differences in the number of positive cells between Con and knockouts. 
C. WB shows comparable levels of Cyclin-D1 at 40, 72 and 96 hours after PH. 
D. Q-PCR analysis of Wnt5a expression in total liver tissue shows significant differences between Con and KO at 
baseline and 24 & 40 hours after PH, while no differences at later times (*p<0.05). 
 
 
4.2.3 The role of hepatic stellate cells in Wnt secretion 
After ruling out the role of hepatocytes and cholangiocytes as a source of Wnt proteins that 
regulate β-catenin activation in liver homeostasis and LR, we next tested the possibility of hepatic 
stellate cells (HSC) being a relevant source of Wnt ligands. Stellate cell specific Wls knockout 
mice (Wls-SKO) were generated to address the role of hepatic stellate cells in Wnt secretion.  
4.2.3.1 Generation and baseline characterization of stellate cell-specific Wls knockout mice 
The Wls-floxed mice were bred with mice that express Cre recombinase under control of 
the glial fibrillary acidic protein (GFAP) promoter [111], to generate stellate cell specific Wls 
knockout mice (Wls
flox/flox
; GFAP-Cre
+/-
), referred to as (Wls-SKO). PCR was used to identify the 
Wls-SKO and Con (Figure 25A). Decreased levels of Wls protein were evident by WB from Wls-
SKO livers (Figure 25B). Although GFAP-Cre mice have been widely used to generate HSC 
specific null animal models [130-132], there is some controversy as to whether GFAP-Cre can 
effectively target HSCs [133], therefore, in order to validate this model, we isolated HSCs from 
Con and Wls-SKO livers (as described in the method section), with the high purity of HSCs 
confirmed by q-PCR (Figure 15). Wls expression in HSCs from Con and Wls-SKO was determined 
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by q-PCR. As expected, there was a dramatic reduction in Wls expression in HSCs from Wls-SKO 
(Figure 25C).  
Eight-month-old Wls-SKO and Con mice had comparable and normal serum levels of AST, 
ALT, bilirubin and albumin (data not shown). Wls-SKO displayed smaller livers and LW/BW ratio 
was significantly lower in Wls-SKO compared to Con (Figure 25D). To address the discrepancy in 
liver size, we assessed hepatocytes in S-phase by PCNA IHC. Surprisingly, Wls-SKO livers had 
comparable PCNA positive cells with Con at baseline (Figure 25E, 25F). Cyclin-D1 expression 
was also comparable between Wls-SKO and Con by WB (Figure 25G). Since GFAP is also 
expressed in other cell populations, such as enteric glial cells of the small intestine [134] and 
astrocytes of the brain [111, 135], the reduction in liver size might be subsequent effect caused by 
the defect of Wls in other organ systems rather than in the liver. 
 
4.2.3.2 Normal adherens junctions and hepatic zonation in Wls-SKO null mice 
Next, we investigated changes in β-catenin, its downstream signaling and junctional 
proteins in Wls-SKO mice. β-Catenin, γ-catenin and E-cadherin were unchanged in Wls-SKO 
(Figure 25G). The expression of the downstream targets of β-catenin signaling was comparable 
between Wls-SKO and Con (Figure 25G). IHC for pericentral expression of β-catenin targets 
showed no differences in staining for GS, Cyp1a2 and Cyp2e1 between Wls-SKO and Con (Figure 
26A). Therefore, blocking Wnt secretion from hepatic stellate cells does not affect regulation of 
zonation by β-catenin signaling. 
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Figure 25. Successful deletion of Wls in Wls-SKO mice 
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A. Representative PCR shows genotype of mice for identifying the Wls
flox/flox 
; GFAP-Cre+/- (Wls-SKO) (lane 3). Mice 
with genotype Wls
flox/wt 
; GFAP-Cre-/- & Wls
flox/flox
 ;GFAP-Cre-/- (lanes 2 & 4) were used as Con.  
B. WB shows an evident decrease in Wls in liver of Wls-SKO compared to Con.  
C. Wls expression in isolated hepatic stellate cells shows a significant reduction of Wls mRNA level in Wls-SKO 
compared to Con, **p<0.01.  
D. Significantly lower LW/BW ratio in 8-month old Wls-SKO as compared to Con, *p<0.05.  
E. IHC shows occasional PCNA-positive hepatocyte in Con and Wls-SKO liver (200X).  
F. Quantification of PCNA staining (200X) shows comparable number of positive hepatocytes between Con and Wls-
SKO.  
G. Representative WB shows comparable expression of β-catenin, relevant junctional components and β-catenin 
downstream, targets in Wls-SKO and Con livers. Prolonged exposure of Cyclin-D1 WB film shows comparable 
Cyclin-D1 in Wls-SKO and Con at baseline. 
 
 
4.2.3.3 Normal initiation of liver regeneration in Wls-SKO mice 
The role of hepatic stellate cell-derived Wnt proteins in LR was examined next by 
subjecting the Wls-SKO and Con to PH. PCNA staining showed comparably high numbers of 
positive cells in Wls-SKO and Con mice at 40 hours post-PH (Figure 26B). Quantification of 
PCNA staining showed no significant differences (Figure 26C). Likewise, Wls-SKO had 
comparable Cyclin-D1 levels to Con at 40 hours (Figure 26D). Analysis at 96 hours after PH also 
revealed no difference in PCNA-positivity between the Wls-SKO and Con group (Figure 26B and 
26C). Therefore, lack of any differences in LR kinetics indicates that β-catenin activation during 
LR is not dependent on stellate cell-derived Wnts. 
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Figure 26. Ablation of Wls in liver stellate cells has no effect on hepatic zonation or initiation of LR 
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A. IHC for GS, Cyp1a2 and Cyp2e1 in Con and Wls-SKO shows normal pericentral localization in both groups 
(100x). 
B. PCNA IHC shows comparable numbers of PCNA-positive hepatocytes in Con and Wls-SKO livers at 40 hours and 
96 hour after PH (200X). 
C. Quantification of PCNA staining confirms similar numbers of PCNA-positive hepatocytes in Con and Wls-SKO at 
40 hours and 96 hours after PH. 
D. Representative WB shows comparable Cyclin-D1 expression at 40 hours after PH in both Con and Wls-SKO livers. 
 
 
4.2.4 The role of macrophages in Wnt secretion 
After ruling out the role of hepatocytes, cholangiocytes and hepatic stellate cells as a source 
of Wnt proteins that regulate β-catenin activation in liver homeostasis and LR, we further we 
generated macrophage specific Wls KO to address the role of macrophages in Wnt secretion and β-
catenin activation.  
4.2.4.1 Generation and baseline characterization of macrophage-specific Wls knockout mice 
To generate macrophage-specific Wls null mice (Wls-MKO), we bred the Wls-floxed mice 
to Lyz2-Cre mice [136]. PCR was used to identify the Wls-MKO and Con (Figure 27A). Decreased 
level of Wls protein from Wls-MKO livers was evident by WB (Figure 27A). To verify successful 
loss of Wls, Kupffer cells were isolated by QuadroMACS column separation as discussed in 
methods and stained for marker F4/80 to demonstrate a notable enrichment (Figure 27B). Q-PCR 
performed on enriched Kupffer cell-fractions showed a significant decrease in Wls expression in 
Wls-MKO as compared to Con (Figure 27B). 
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Eight-month-old Wls-MKO and Con mice had comparable and normal serum levels of 
AST, ALT, bilirubin and albumin (data not shown). Wls-MKO mice (n=5) had marginally smaller 
livers than Con (n=3); however the difference did not reach statistical significance (p=0.079) 
(Figure 27C). IHC for PCNA identified fewer positive cells in Wls-MKO, although differences 
were not statistically significant (Figure 27D, 27E). Intriguingly, a notable decrease in baseline 
Cyclin-D1 protein expression was evident in Wls-MKO (Figure 27F). Hence, we conclude that 
macrophages may secrete Wnts and contribute to baseline hepatocyte turnover to govern liver size. 
4.2.4.2 Normal adherens junctions and hepatic zonation in Wls-MKO mice 
Next, the effect of abolishing Wnt secretion from macrophages on β-catenin levels and 
other related junctional proteins was assessed. WB showed no notable changes in the levels of β-
catenin, γ-catenin or E-cadherin in Wls-MKO when compared to Con livers (Figure 27F). WB also 
showed comparable levels of Regucalcin, GS, Cyp1a2 & Cyp2e1 in Wls-MKO and Con livers 
(Figure 27F). More importantly, comparable GS, Cyp1a2 and Cyp2e1 localization confined to the 
pericentral area was evident in Wls-MKO and Con livers (Figure 28). Thus, blocking Wnt 
secretion from macrophages does not have any effect on β-catenin at adherens junctions or in 
metabolic zonation. 
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Figure 27. Impact of deletion of Wls in Kupffer cells on hepatic homeostasis 
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A. Representative PCR (left) showing genotype of Wls-MKO (Wls
flox/flox 
; Lyz2-Cre+/-) (lane 3) and Con with 
genotype Wls
flox/wt 
; Lyz2-Cre-/- & Wls
flox/flox 
;Lyz2-Cre-/- (lanes 2 & 4). Representative WB shows a notable decrease 
in Wls in Wls-MKO liver lysate. 
B. Enrichment for Kupffer cells after collagenase perfusion and column separation of non-parenchymal cells is 
verified by immunocytochemistry on cytospin for F4/80 (red) showing positive staining in the F4/80-positive cell 
fraction and not in F4/80-negative fraction (left). Wls mRNA expression in F4/80+ cells isolated from Con and Wls-
MKO, shows significantly lower expression in the latter (**p<0.001). 
C. Bar graph depicts marginally lower LW/BW ratio in Wls-MKO, although difference was not statistically 
significant. 
D. IHC (200X) shows an occasional PCNA-positive hepatocytes in Con at baseline (arrow), while no positive cell is 
observed in a representative view in Wls-MKO. 
E. Quantification of PCNA staining showing less positive cells in Wls-MKO than Con at baseline, although 
differences were insignificant. 
F. WB shows no alteration in proteins levels of β-catenin, junctional proteins and pericentral targets. However Cyclin-
D1 was notably lower in Wls-MKO livers. 
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Figure 28. No defect in pericentral zonation in Wls-MKO 
Immunohistochemistry shows normal pericentral localization of GS, Cyp1a2 and Cyp2e1 in Con livers. In Wls-MKO 
livers, comparable expression pattern was evident.  
 
4.2.4.3 Suboptimal liver regeneration in Wls-MKO mice  
To address the role of macrophage derived Wnts in LR, Wls-MKO and Con mice were 
subjected to PH. At 40 hours after PH, a notable decrease in PCNA-positive hepatocytes was 
observed in Wls-MKO, however at 72 hours no difference was seen (Figure 29A). Upon 
quantification, this deficit at 40 hours was found to be around 33% and significant (Figure 29C). In 
addition, numbers of mitotic figures as assessed by analysis of H&E images from Wls-MKO and 
Con showed significantly lower mitosis in hepatocytes in the former at 40 hours (Figure 29B, 
29D).  
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Figure 29. Dampened LR in Wls-MKO after PH 
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A. IHC (200X) showing many PCNA-positive hepatocytes in Con livers at 40 hours and 72 hours; however several 
PCNA-negative hepatocytes were observed in Wls-MKO at 40 hours. 
B. Mitotic figures show less cells undergoing mitosis in Wls-MKO at 40 hours after PH. 
C. Quantification of PCNA staining showing a 33% and significant decrease in the number of hepatocytes in S-phase 
in Wls-MKO at 40 hours (**p<0.01). 
D. Quantification of mitotic figures shows a significantly lower numbers in Wls-MKO as compared at Con at 40 hours 
after PH. (*p<0.05). 
 
WB showed a concomitant decrease in Cyclin-D1 at 40 hours in Wls-MKO (Figure 30A). 
Co-precipitation studies showed a notable decrease in β-catenin-TCF4 complex in Wls-MKO livers 
at 4 hours after PH (Figure 30B). This indicates that β-catenin activation in hepatocytes after PH is 
at least in part regulated by Wnts derived from Kupffer cells. 
 
Figure 30. Impaired β-catenin activation in Wls-MKO after PH 
A. Representative WB shows lower Cyclin-D1 levels in Wls-MKO at 40 hours after PH. 
B. A representative immunoprecipitation study shows decreased TCF4-β-catenin complex formation at 4 hours after 
PH in Wls-MKO when compared to Con. Immunoprecipitation studies were performed by pull down of either β-
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catenin or TCF4. Respective input controls are included in analysis as well. 
 
4.2.5 The role of endothelial cells in Wnt secretion 
Liver endothelial cells are known to have important roles in maintaining hepatic zonation 
and triggering LR [102, 137]. Our q-PCR data shows a dramatic induction of Wnt expression in 
liver endothelial cells after PH (Figure 17, Table 2), which suggests that endothelial cells might be 
playing a critical role in Wnt secretion. To test our hypothesis, we generated endothelial cell 
specific Wls null mice, and analyzed their zonation and LR kinetics. 
4.2.5.1 Generation of endothelial cell-specific Wls null mice using Tie2-Cre  
Deletion of Wls using Tie2-Cre [138] led to no viable pups suggesting embryonic lethality. 
Heterozygous mice that lacked an allele of Wls in endothelial cells showed no decrease in Wls 
protein and these livers did not show any decrease in pericentral targets (Figure 31). When 
subjected to PH, no defect in LR was observed in heterozygous knockout animals (Figure 31). 
 
Figure 31. Heterozygous endothelial cell specific Wls knockouts have normal zonation and LR 
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No difference was observed in Wls and GS protein levels between Con and heterozygous knockouts (H). After PH, the 
heterozygous knockouts had sufficient Cyclin-D1 induction. 
 
4.2.5.2 Generation of endothelial cell-specific Wls null mice using VE-cadherin-CreERT2 
To study Wnt secretion from endothelial cells in adult mice, we bred Wls
flox/flox
 mice with 
VE-cadherin-CreER
T2+/- 
to generate viable endothelial cell specific Wls null mice (Wls-EKO) 
[114]. VE-cadherin-CreER
T2
 mice have been widely used to generate inducible endothelial cell 
specific knockout models, and it has been shown that Cre-recombinase activity is present in the 
liver endothelial cells, including both the endothelial cells lining the central vein and the sinusoidal 
endothelial cells [114]. This therefore allowed us to elucidate the role of liver endothelial cells in 
Wnt secretion. PCR was performed to identify knockout and control animals (Figure 32). Mice 
with genotype Wls
flox/flox
;VE-cadherin-CreER
T2+/- 
are homozygous inducible Wls knockouts, 
referred to as Wls-iEKO, and mice with genotype  Wls
flox/flox
;VE-cadherin-CreER
T2-/- 
and 
Wls
flox/wt
;VE-cadherin-CreER
T2-/- 
are used as control (Con). Six- to eight-week old Wls-iEKO and 
Con mice were treated with Tamoxifen (Tm) to induce Cre-recombinase activity, generating Wls-
EKO mice. All the animals appear to be normal after Tm treatment. 
 
Figure 32. PCR shows genotype of mice for identifying Wls-iEKO 
Representative PCR (upper panel) shows genotype of mice for identifying Wls-iEKO with genotype Wls
flox/flox
;VE-
 86 
cadherin-CreER
T2+/-
 (lane 3). Mice with genotypes Wls
flox/wt
;VE-cadherin-CreER
T2-/- 
(lane 2) and Wls
flox/flox
;VE-
cadherin-CreER
T2-/- 
(lane 4) are used as control (Con).  
 
4.2.5.3 Baseline characterization of Wls-EKO after Tamoxifen treatment 
Livers were harvested one week, two weeks and four weeks following the last injection of 
Tm. A dramatic reduction in Wls protein level was observed in livers from Wls-EKO at all the 
time points after Tm treatment, which suggests that Tm treatment has successfully deleted Wls 
from endothelial cells. However, no obvious alterations were observed in the components of the β-
catenin signaling pathway except for lower Cyp1a2 expression in the Wls-EKO animals (Figure 
33). Immunohistochemistry (IHC) on liver tissues one week after Tm treatment showed normal GS 
and Cyp2e1 expression in the pericentral zone, with lower Cyp1a2 expression in Wls-EKO (Figure 
34).  
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Figure 33. Baseline characterization of Wls-EKO after Tamoxifen treatment 
Western blot shows a dramatic reduction of Wls protein expression in the Wls-EKO one week, two weeks and four 
weeks after Tm treatment, while no alteration in β-catenin signaling pathway was observed except for lower Cyp1a2 
expression in the Wls-EKO.  
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Figure 34. Zonation of Wls-EKO one week after Tamoxifen treatment 
IHC on liver tissues of mice one week after Tm treatment shows comparable staining for GS and Cyp2e1 in Wls-EKO 
and Con, while Cyp1a2 expression was notably reduced in Wls-EKO compared to Con. 
 
 
Next, q-PCR was performed to examine the pericentral gene expression at different time 
points after Tm treatment (Figure 35). An obvious reduction in the mRNA expression of GS, 
Cyp1a2 and Cyp2e1 was observed in Wls-EKO, one week and two weeks after Tm treatment. 
However, three and four weeks after treatment, there was an increase in the expression of zonation 
markers in the Wls-EKO (Figure 35). 
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Figure 35. Changes of the expression of zonation genes in Wls-EKO after Tm treatment 
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(A) Ratio of GS expression in Wls-EKO over Con shows decreased expression of GS in Wls-EKO one and two weeks 
after Tm treatment, however, three weeks and four weeks after Tm treatment, GS expression begins to increase in the 
Wls-EKO. The expression of Cyp1a2 (B) and Cyp2e1 (C) shows the same trend. 
 
 
One and two weeks after Tm treatment, the reduction in mRNA expression of the zonation 
genes suggests that endothelial cell derived Wnts may play an important role in maintaining 
hepatic zonation. However, we did not observe a decrease in GS and Cyp2e1 protein level. Since 
the half-life of these enzymes in mouse liver is unknown, it could be that the half-life is longer 
than we expected, therefore the residual proteins persist when we analyzed zonation one or two 
weeks after Tm injection. However, three to four weeks after Tm treatment, the increased 
expression of zonation genes in Wls-EKO might be due to repopulation of endothelial cells derived 
from progenitor cell populations or the compensation of Wnt secretion from other cell types in the 
liver.  
 
4.2.5.4 Suboptimal liver regeneration in Wls-EKO one week after Tamoxifen treatment 
To address the role of endothelial cell derived Wnts in LR, PH was performed on Con and 
Wls-EKO one week following the Tm treatment, and LR kinetics were analyzed by PCNA and 
Cyclin-D1 staining. At 40 hours after PH, a notable decrease in PCNA and Cyclin-D1 positive 
hepatocytes was observed in Wls-EKO (Figure 36A). Upon quantification, this deficit at 40 hours 
was found to be around 50% and significant (Figure 36B, 36C). This indicates that β-catenin 
activation in hepatocytes after PH is in part regulated by Wnts derived from endothelial cells. 
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Figure 36. Suboptimal LR in Wls-EKO after PH 
A. PCNA and CyclinD1 staining showing less positive cells in Wls-EKO 40 hours after PH compared to Con (100X).  
B. Quantification of the PCNA staining (200X) shows a significant reduction in the number of PCNA positive cells 40 
hours after PH in Wls-EKO (**p<0.01).  
C. Quantification of the Cyclin-D1 staining (200X) shows a significant reduction in the number of Cyclin-D1 positive 
cells 40 hours after PH in Wls-EKO (*p<0.05). 
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5.0  DISCUSSION 
5.1 THE ROLE OF WNT/BETA-CATENIN SIGNALING IN LIVER HOMEOSTASIS 
AND LIVER REGENERATION 
β-Catenin, a critical downstream effector of Wnt signaling, acts as a coactivator for TCF 
family of transcription factors to regulate expression of several target genes in a tissue specific 
manner. Deletion of β-catenin in hepatocytes has yielded two major phenotypes in the liver [48, 
49]. The first observation at baseline is a defect in metabolic zonation as β-Catenin-LKO mice lack 
several downstream targets in pericentral hepatocytes such as genes encoding for GS (ammonia 
metabolism), Cyp2e1, Cyp1a2 (xenobiotic metabolism) and others involved in glycolytic pathway 
and Tricarboxylic acid (TCA) cycle [139]. The second phenotype in β-catenin-LKO mice was a 
defect in LR after PH. The role of β-catenin signaling in LR is now well established in rodents, 
zebrafish and patients [70, 106]. Activation of β-catenin is relatively early with its nuclear 
translocation evident in minutes to hours after PH, where it complexes with TCF4 to regulate the 
expression of Ccnd1. Cyclin-D1 is critical for driving G1 to S phase cell cycle progression and 
marks the point of no return for cell proliferation [140]. In fact absence of β-catenin in hepatocytes 
in β-Catenin-LKO led to a significant lag in the initiation of LR with hepatocyte S-phase peaking 
at 72 hours instead of 40 hours due to decreased Cyclin-D1 [49, 69]. 
Endogenous or exogenous activation of β-catenin has been shown to improve LR in animal 
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models as well as in patients [71, 141, 142]. However, for translational exploitation of β-catenin 
signaling in regenerative medicine, it will be critical to understand the cellular and molecular 
circuitry upstream of β-catenin activation in hepatocytes at baseline and during LR. This is of 
special relevance since β-catenin activation has also been shown to occur downstream of non-Wnt 
mechanisms such as those mediated by HGF, EGF, Flt3 and PKA, which have been independently 
shown to be playing a significant role in LR after PH [143]. 
In the current study using genetic mouse models we address the key regulators of β-catenin 
in hepatic zonation and LR. We used genetic knockout of Lrp5 and Lrp6 to disrupt Wnt signaling 
in hepatocytes and cholangiocytes using Albumin-Cre, which was also used by us to delete β-
catenin in the same two cell-types previously [49, 144]. Deleting both Lrp5 and Lrp6 has been 
shown to prevent any compensation and hence assures complete abrogation of Wnt signaling 
[109], while it has no effect on Wnt-independent pathways. β-Catenin protein levels and 
localization were not altered in Lrp-LKO, therefore allowing us to investigate the upstream 
signaling that regulates the activation of β-catenin in liver homeostasis and LR.   
The breach in Wnt signaling in Lrp-LKO prevented pericentral β-catenin activation and led 
to defect of hepatic zonation. Expression of pericentral markers, GS, Cyp1a2 and Cyp2e1, were 
abolished in Lrp-LKO, which phenocopied β-catenin-LKO. This finding demonstrates that the 
pericentral zonation function of β-catenin is fully regulated by Wnt signaling (Figure 37).  
A more surprising result came from the analysis of LR in this model. Despite β-catenin 
activation by many non-Wnt dependent mechanisms and despite the physiological activation of 
such pathways as HGF, EGF and PKA after PH, there was a considerable deficit in LR in the Lrp-
LKO similar to β-catenin-LKO mice as seen by decreased PCNA at 40 and 72 hours and reduced 
mitosis at 72 hours [49, 63]. Intriguingly, while β-catenin-LKO showed comparable numbers of 
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hepatocytes in S-phase versus Con at 72 hours, the Lrp-LKO continued to show fewer hepatocytes 
in S-phase at this time as compared to their littermate controls. However the numbers of 
hepatocytes in S-phase were notably greater at 72 hours than the 40-hour time-point, suggesting 
redundant mechanisms that compensate, which as what was observed in β-catenin-LKO as well. 
An increase in Cyclin-D1 at 72 hours in regenerating Lrp-LKO livers over baseline and 40 hours 
suggests sufficient LR to restore the smaller baseline hepatic mass in Lrp-LKO. No alternate 
mechanism of β-catenin activation in regenerating Lrp-LKO livers was observed at any time. 
Although β-catenin remains intact, it fails to be activated after PH, as shown by lack of β-catenin 
and TCF4 complex in Lrp-LKO. Thus Wnt signaling strictly regulates β-catenin during the process 
of LR (Figure 37). 
 
Figure 37. Wnt-signaling is the determinant pathway that regulates β-catenin activation 
In β-catenin-LKO, β-catenin is deleted from hepatocytes and cholangiocytes, which abolishes both Wnt-dependent and 
Wnt-independent signaling; while in LRP-LKO, only Wnt-signaling is abrogated, β-catenin remains intact and can be 
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activated by Wnt-independent pathways. Lrp-LKO phenocopied β-catenin-LKO in defective liver zonation and delay 
in liver regeneration, suggesting that β-catenin activation in these processes is strictly regulated by Wnt-signaling. 
 
5.2 THE ROLE OF INDIVIDUAL HEPATIC CELL POPULATIONS IN WNT 
SECRETION 
To determine the cellular source of Wnt ligands at baseline and after PH is challenging as 
several hepatic cell types express multiple Wnts [82]. An exciting development to address the role 
of global Wnt signaling has been to interfere with either their biological activity or prevent their 
secretion from a cell. Deletion of the gene encoding for porcupine, which is responsible for 
glycosylation and acylation of Wnt proteins, has been used to disrupt Wnt function [145]. Another 
relevant protein, Wntless (Wls), has been shown to be indispensable for Wnt secretion [85]. In 
fact, conditional deletion of Wls has been used in various organ systems to address cell-specific 
Wnt secretion under spatial and temporal control [94]. Studies show that deletion of Wls using 
Wnt1-Cre phenocopies Wnt1-null abnormalities in brain [95, 146]. Conditional deletion of Wls has 
revealed the crucial role of Wnt ligands in bone development and homeostasis, retina angiogenesis, 
maintaining stem cell activity and other important biological events [95-98]. Therefore, depletion 
of Wls from individual hepatic cell populations, including hepatocyte, cholangiocytes, Kupffer 
cells, stellate cells and endothelial cells, would be a powerful tool to address the source of Wnt 
ligands in the liver. 
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5.2.1 The role of liver epithelial cells in Wnt secretion 
Utilizing Wls-floxed mice, we blocked Wnt secretion from hepatocytes and cholangiocytes. 
Western blot shows only a modest reduction in Wls protein level in the Wls-LKO livers, which 
suggests that the other hepatic cell populations also express Wls and are capable of Wnt secretion. 
Indeed, cell fractionation into parenchymal and non-parenchymal cells showed notably higher Wls 
expression in the nonparenchymal cell compartment. 
5.2.1.1 The role of liver epithelial cell derived Wnts in hepatic zonation and initiation of LR 
Our results showed no alteration in either pericentral gene expression, or in the initiation of 
LR when Wnt-secretion was ablated from hepatocytes and cholangiocytes, therefore, rule out the 
possibility that hepatocytes and cholangiocytes as the source of Wnt ligands that regulate β-catenin 
activation in these processes. Our q-PCR analysis of Wnt expression in hepatic cell populations 
also shows very modest induction of stimulatory Wnt ligands (such as Wnt2) after PH in the 
hepatocytes, with robust induction in the endothelial cells and macrophages, further confirming 
that liver parenchymal cells might not be the source of activating Wnt ligands during LR. 
Liver regeneration after PH features the proliferation of adult hepatic cell types. 
Hepatocytes have enormous proliferative potential, and they are the first to proliferate after PH. 
The first peak of DNA synthesis in hepatocytes occurs around 24 h after PH in rats and 
approximately 36 h in mice [55]. Cholangiocytes, stellate cells and endothelial cells all start to 
proliferate after hepatocytes [55, 58, 59]. β-Catenin plays an essential role in triggering hepatocyte 
proliferation after PH. β-catenin activation in hepatocytes can be observed very shortly after PH 
[65], while a defect of β-catenin leads to a delay in hepatocyte proliferation [49]. Our findings 
suggest that hepatocytes are not the source of Wnt ligands that activate β-catenin during LR. 
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However, hepatocytes can respond to the Wnt signals secreted by other cell populations and 
proliferate earlier than them. Therefore, there might be some regulatory mechanisms by which 
hepatocytes are the first to respond to the activating Wnt signals after PH. Gene array analysis in 
individual hepatic cell populations before and after PH might help to identify the genes playing 
important roles in this process. 
5.2.1.2 The role of liver epithelial cell derived Wnts in the termination of LR 
Our experiments showed a temporarily enhanced LR and prolonged activation of β-catenin 
signaling in Wls-LKO at later stages of LR. In Con, there was an induction of Wnt5a signaling, an 
inhibitor of the Wnt/β-catenin pathway, which was absent in Wls-LKO. Therefore, we 
hypothesized that hepatocytes might be able to secrete inhibitory Wnt ligands such as Wnt5a to 
terminate LR, while Wls-LKO has a defect in Wnt secretion from hepatocytes which leads to 
sustained LR. By ELISA, we did confirm that Con hepatocytes were capable of secreting Wnt5a 
after PH, while the hepatocytes from Wls-LKO failed to, which further supports our hypothesis.  
Next, we aimed to investigate the role of Wnt5a in LR, and thus liver epithelial cell specific 
Wnt5a knockout mice were generated. Wnt5a-LKO livers had slightly less Wnt5a protein and 
mRNA levels at baseline, suggesting that other liver cell populations also express Wnt5a. 
Surprisingly, Wnt5a-LKO exhibited no alteration in LR kinetics after PH. Q-PCR analysis for 
Wnt5a expression in total liver tissue showed mild but significant differences between Con and 
Wnt5a-LKO 24 and 40 hours after PH, while no differences at later time points, which indicates 
that other liver cell populations can secrete Wnt5a to compensate for the loss of liver epithelial cell 
derived Wnt5a. Other signaling pathways involved in the termination of LR, such as TGFβ, ILK 
and GPC3, may also become active to ensure the proper termination of LR in Wnt5a-LKO.  
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However, there is some discrepancy in phenotypes between the two animal models: Wls-
LKO exhibits sustained LR, while the Wnt5a-LKO has normal LR kinetics. Numerous reasons 
could cause the discrepancy. All Wnt secretion from liver epithelial cells is blocked in Wls-LKO, 
while only Wnt5a is deleted in the Wnt5a-LKO. Liver epithelial cells might be able to secrete other 
inhibitory Wnt ligands to terminate LR, and thus ablation of Wnt5a alone is not sufficient to cause 
any phenotype. Analyzing the expression of all the Wnt ligands at different time points after PH in 
Con and knockouts might help identifying candidates of inhibitory Wnts being upregulated during 
later stage of LR to inhibit β-catenin activation and terminate LR. Another possible reason is that 
ablation of liver epithelial cell derived Wnt5a might be compensated by the Wnt5a secreted by 
other liver cell populations, therefore Wls-LKO only show temporarily enhanced LR, while 
Wnt5a-LKO have normal LR kinetics. Examining Wnt5a expression in individual cell populations 
during late stages of LR might be helpful to address the source of Wnt5a in both Con and knockout 
animals. Finally, the Wls-LKO and Wnt5a-LKO were generated in different genetic background. 
The strain difference might also contribute to the observed discrepancy in phenotypes. 
 
 
5.2.2 The role of hepatic stellate cells in Wnt secretion  
To elucidate the role of hepatic stellate cells in Wnt secretion, we generated stellate cell 
specific Wls knockout (Wls-SKO) by breeding Wls floxed mice to GFAP-Cre mice [111]. GFAP is 
believed to be a marker for hepatic stellate cells [147-150], and GFAP-Cre mice have been widely 
used to generate HSC specific null animal models [130-132]. However, there is still controversy 
on whether GFAP-Cre can efficiently target HSCs [133]. Therefore, to verify successful loss of 
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Wls in HSCs, we compared Wls expression in HSCs isolated from Con and Wls-SKO livers. As 
expected, there was a dramatic reduction in Wls expression in HSCs from Wls-SKO, which 
confirmed that our animal model was valid. 
We further characterized the Wls-SKO at baseline. Wls-SKO livers appear to be 
histologically normal and do not have any liver injuries (data not shown). No alteration was 
observed in Wls-SKO, except for slightly lower LW/BW ratio compared to Con. To address the 
mechanism for this phenotype, we examined the baseline proliferation by PCNA staining and 
Cylin-D1 expression. Surprisingly, no obvious alteration was found in Wls-SKO. However, GFAP 
is not only expressed in hepatic stellate cells, but also in several other cell populations, such as 
enteric glial cell of small intestine [134] and astrocytes in the brain [111, 135]. Therefore the 
smaller liver size could be consequent effect resulted from the defect of Wls in other organs rather 
than in the liver. 
Next, we examined hepatic zonation and LR. Our results show no alteration in either 
pericentral gene expression, or in the initiation of LR when Wnt-secretion was ablated from 
hepatic stellate cells. Therefore, our findings rule out HSCs as the source of Wnt proteins that 
regulate β-catenin activation in liver homeostasis and LR.  
HSCs are the main source of extracellular matrix (ECM), thus playing an essential role in 
liver fibrosis. In chronic liver diseases, injuries activate and transform quiescent HSCs which then 
become activated myofibroblasts, and it is the central pathogenic mechanism behind liver fibrosis 
[151, 152]. Meanwhile, Wnt/β-catenin signaling has been demonstrated to play important roles in 
HSC development and liver fibrosis [153, 154].
 
Activation of the Wnt/β-catenin pathway by a Wnt 
agonist activates HSCs and promotes liver fibrosis [155], while inhibition of Wnt/β-catenin 
signaling attenuates liver fibrosis [156]. Although our study suggests that Wnt ligands secreted by 
 100 
HSCs are dispensable for the activation of β-catenin in liver homeostasis and during LR, a more 
important role of the HSC derived Wnt ligands might lie in liver fibrogenesis. Therefore, we 
further plan to address the role of HSC derived Wnt proteins in the context of liver fibrosis. Since 
inhibition of the activation and function of HSCs has become the most important treatment 
strategy for liver fibrosis [152], our new study will aim to elucidate the upstream signaling leading 
to HSC activation and how it might bear significant clinical relevance.  
 
 
5.2.3 The role of Kupffer cells in Wnt secretion 
To elucidate the role of Kupffer cells in Wnt secretion, we generated macrophage specific 
Wls knockout (Wls-MKO) by breeding Wls floxed mice to Lyz2-Cre mice [136]. Lyz2-Cre mice 
have been widely used to generate myeloid cell specific conditional knockouts [136]. To verify 
successful loss of Wls, Kupffer cells were isolated. Q-PCR performed on enriched Kupffer cell-
fractions showed a significant decrease in Wls expression in Wls-MKO as compared to Con. 
Based on our study, abrogating Wnt secretion from Kupffer cells results in no defects in 
metabolic zonation. GS, Cyp1a2 and Cyp2e1 expression were not altered in pericentral 
hepatocytes. However, when the animals were subjected to PH, a 33% decrease in S-phase 
hepatocytes and hepatocyte mitosis was evident in Wls-MKO at 40 hours after PH. This coincided 
with a notable decrease in β-catenin-TCF4 complex and Cyclin-D1 expression after PH. These 
observations are consistent with the dramatic induction of Wnt2 expression in the Kupffer cells 12 
hours after PH (Table. 2). Taken together, our findings suggest that Kupffer cells are an important 
source of Wnt proteins that activate hepatocyte β-catenin in a paracrine manner during LR.  
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Indeed, the important role of Kupffer cells in liver regeneration has been well established. 
Studies suggest that Kupffer cells are crucial for LR because of their ability to produce growth 
factors and cytokines contributing to LR [157]. Depletion of Kupffer cells in rodents results in 
delayed liver regeneration, caused by reduced expression of important growth factors or an 
imbalanced hepatic cytokine expression [158, 159]. Our study further confirms the importance of 
Kupffer cells in LR by elucidating their role in Wnt secretion and β-catenin activation during LR.  
 
 
5.2.4 The role of endothelial cells in Wnt secretion 
Endothelial cells are believed to have critical roles in maintaining liver homeostasis and 
triggering LR [102, 137]. In normal liver, β-catenin is activated in pericentral hepatocytes, which 
dictates pericentral zonation. Wnt signals emanating from the endothelial cells of the central vein 
may activate β-catenin in the pericentral hepatocytes [137]. During LR after PH, liver sinusoidal 
endothelial cells secrete pro-proliferative signals, such as HGF and Wnt2, to induce hepatocyte 
proliferation [102]. Our Wnt expression analysis in individual liver cell populations shows a 
dramatic induction of Wnt2 and Wnt9b expression in the endothelial cells after PH, which again 
suggests an important role of the endothelial cells in Wnt secretion. 
To address the role of endothelial cells in Wnt secretion, we first utilized Tie2-Cre to 
deplete Wls from endothelial cells. Tie2-Cre mediated Wls deletion led to embryonic lethality, 
which was not surprising because of the many important roles of Wnt/β-catenin signaling in 
vasculogenesis and angiogenesis [160, 161]. While embryonic lethality precluded us from 
addressing the role of hepatic sinusoidal endothelial cells and of endothelial cells lining the hepatic 
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vessel walls, viable heterozygous knockouts did not show any notable decrease in Wls. 
Simultaneously, no defects in hepatic zonation or LR were observed.  
Next, we generated Tamoxifen (Tm) inducible-conditional Wls-iEKO to elucidate the 
endothelial-hepatocyte paracrine interactions in the liver. WB shows a dramatic reduction of Wls 
expression in livers from Wls-EKO after Tm treatment, which suggests that Wls is deleted in the 
endothelial cells. Zonation and LR were analyzed at different time points after Tm treatment. Our 
experiments show an obvious reduction in the mRNA expression of all zonation markers in Wls-
EKO one and two weeks after Tm treatment. Therefore, endothelial cell secreted Wnts might play 
an important role in regulating zonal gene expression. However, three and four weeks after 
treatment, there is an increase in the mRNA expression of zonation genes in the knockouts. 
Numerous reasons can explain this phenotype and need to be validated in future experiments. 
Compensation of Wnt secretion from other cell populations could be a possible cause for 
the increased expression of zonation markers at later time points after Tm. Endothelial cell derived 
Wnts might be important for maintaining zonation; however, other cell populations in the liver can 
also secrete Wnts and might be able to compensate for the lack of Wnts secreted by endothelial 
cells. If so, animal models with Wls deleted from two or more hepatic cell populations must be 
generated, to address two or more cell populations together being the source of Wnt ligands that 
dictate liver zonation. Another potential reason for this phenotype is the repopulation of 
endothelial cells from progenitor cells. Residing progenitor cells may give rise to endothelial cells, 
and Wls might be expressed in the newly repopulated endothelial cells three or four weeks after 
Tm treatment, as there is no effective Tm to activate Cre-recombinase activity. To test this 
possibility, endothelial cells can be isolated from Wls-EKO livers at earlier and later time points 
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after Tm injection. Analysis of Wls expression will answer the question whether there is 
repopulation of Wls expressing endothelial cells at later time points after Tm injection. 
Given the fact that zonal gene expression increases in Wls-EKO three and four weeks after 
Tm treatment, one or two weeks after injection should be best time points to address the role of 
endothelial cell derived Wnts in regulating zonation. However, one and two weeks after Tm, we 
only observed a decrease in Cyp1a2 protein level, while GS and Cyp2e1 protein level did not 
change. Since the half-life of these enzymes in mouse liver is unknown, it could be that the half-
life is longer than we expected. Therefore, the residual proteins might persist when we analyzed 
zonation one or two weeks after Tm injection, even though the mRNA level was already affected 
by the lack of endothelial cell derived Wnts. In order to fully address the effect of the lack of 
endothelial cell derived Wnts on zonation, we might have to deplete the original store of the 
enzymes at one or two weeks after Tm injection, and analyze zonation afterwards. We plan to 
inject the mice with a sub-lethal dose of acetaminophen to consume Cyp1a2 and Cyp2e1 [121, 122, 
141], or feed the animals with a high protein diet to consume GS [162]. Con mice should be able to 
replenish the store of enzymes efficiently, whereas Wls-EKO should not, thereby leading to a more 
pronounced difference in zonation between Con and Wls-EKO. 
The role of endothelial cells in LR after PH was more apparent. PCNA staining after PH 
showed a notable decrease in the number of positively stained hepatocytes in Wls-EKO 40 hours 
after PH. This indicates that β-catenin activation in hepatocytes after PH is at least in part regulated 
by Wnts derived from endothelial cells. Further, we plan to examine LR kinetics at different time 
points after PH and examine β-catenin activation in both Con and Wls-EKO, to fully address the 
role of endothelial cell derived Wnts in LR. 
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5.2.5 Summary: The role of hepatic cell populations in Wnt secretion 
Our current study demonstrates the regulation of β-catenin in two fundamental processes 
inherent to the liver: hepatic zonation and liver regeneration (LR). In both cases, β-catenin is under 
the control of Wnt signaling only, as abolishing Wnt-dependent signaling compromises pericentral 
gene expression and results in delayed LR. To address the upstream signals that control β-catenin 
activation in these processes, conditional knockout animals that lack the ability of a specific cell 
population to secrete Wnts were generated. Our studies rule out the role of hepatocytes, 
cholangiocytes, stellate cells and Kupffer cells as the source of Wnt proteins that regulate zonation, 
and suggest a potential role of the endothelial cells derived Wnt ligands in this process (Figure 38). 
On the other hand, it became apparent that Wnt secretion from the non-parenchymal cell 
compartment of Kupffer cells and endothelial cells, was required for timely β-catenin activation in 
hepatocytes to initiate LR after PH, while there is some evidence to suggest that hepatocytes might 
secrete inhibitory Wnt ligands involved in the termination of LR (Figure 38).  
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Figure 38. Source of Wnt ligands regulating hepatic zonation and liver regeneration 
Diagrams showing the source of Wnts in regulating zonation and LR. For zonation, hepatocytes, HSCs and 
macrophages are not the source of Wnts. Endothelial cells might play an important role, but the exact role of 
endothelial cells needs to be further investigated. For LR, both macrophages and endothelial cells secrete activating 
Wnt ligands to trigger LR after PH, while hepatocytes might secrete inhibitory Wnts that suppress β-catenin activation 
during late stages of LR. 
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β-catenin plays crucial role in liver homeostasis and regeneration. Wnt-signaling is the 
major pathway that activates β-catenin, while there are Wnt-independent pathways that can also 
activate β-catenin. The goal of the project is to address to what extent β-catenin activation is Wnt-
dependent in both liver homeostasis and during liver regeneration, and elucidate where do the 
Wnts come from.  
Generated LRP5/6 double KO where Wnt-signaling is abolished, while Wnt-independent 
signaling is intact and can activate β-catenin, and compare the phenotype with β-catenin KO where 
β-catenin signaling is totally abolished.  
LRP5/6 KO phenocopied β-catenin KO in defective hepatic zonation and delay in liver 
regeneration (LR), therefore addressed that Wnt-signaling is the major pathway that activates β-
catenin in both liver homeostasis and regeneration. 
Investigated the source of Wnts in liver by generating different cell population specific Wls KO 
that lack the ability of a specific population to secrete Wnts. 
Address a potential role of endothelial cells derived Wnt ligands in regulating basal pericentral 
β-catenin activation in liver, and rule out the role of hepatocytes, cholangiocytes, stellate cells and 
Kupffer cells as the source of Wnt proteins that regulate zonation. 
Address Kupffer cells and endothelial cells are required for timely β-catenin activation in 
hepatocytes to initiate LR after PH, while hepatocytes and hepatic stellate cells derived Wnt 
ligands are not required in this process. 
 
University of Pittsburgh   Department of Pathology 
Graduate Student                                      July.2011-July.2012 
Supervisor: Dr. Paul Monga 
Work on the project of identification of biomarkers indicating β-catenin mutation in 
hepatocellular carcinomas. It has been found that in 30% of HCC patients, β-catenin is mutated. 
Biomarkers indicating β-catenin mutation have strong clinical implications for this subset of HCC 
patients.  
Generated stable cell lines transfected with constitutively activated β-catenin mutation 
constructs. 
Addressed that cell lines transfected with β-catenin mutants have distinct downstream targets. 
